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The concept of gene-environment interaction, or G×E, refers to cases where different genetic 
groups respond differently to the same array of environments for a particular phenotypic trait. In 
a widely acclaimed study from 2002, researchers found a case of G×E for a gene associated with 
neuroenzymatic activity (low vs. high), exposure to childhood maltreatment, and the 
development of antisocial personality disorder (ASPD), or sociopathy. Cases of G×E are 
generally characterized as evincing a genetic predisposition to the trait under consideration; for 
example, individuals with low neuroenzymatic activity are generally characterized as having a 
genetic predisposition to ASPD. Bioethical commentators in turn have asked: Should parents test 
their embryos or fetuses for this genetic predisposition to ASPD in order to screen against the 
gene associated with low-MAOA activity? Should the state test all newborns for this genetic 
predisposition to ASPD in order to identify and treat individuals with the gene associated with 
low-MAOA activity from birth?    
 I first show that the concept of a genetic predisposition fundamentally misconstrues the 
ASPD study. That concept is appropriately applied only to cases of G×E that result in a change 
of scale, but the ASPD study resulted in a change of rank. For cases of G×E that result in a 
change of rank, I introduce a new concept—interactive predisposition. Then, I show how this 
switch from a genetic predisposition to an interactive predisposition reconfigures old questions 
and raises new questions in the confines of the ethical discussions about the implications of such 
studies. For the ASPD study, attempts to screen against the gene associated with low-MAOA 
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activity potentially fall prey to the myth of pre-environmental prediction, and attempts to screen 
all newborns for the gene associated with low-MAOA activity with an eye towards early 
intervention will have to face the interventionist’s dilemma. Moving beyond the ASPD study, 
traditional cost-benefit analyses involved in deciding whether or not to undertake the genetic 
testing of a child will have to be reweighed when the disease/disorder of concern results from an 
interactive predisposition rather than a genetic predisposition.   
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1. INTRODUCTION  
This thesis is about gene-environment interaction, or G×E. G×E refers to cases where different 
genetic groups respond differently to the same array of environments. For instance, a very early 
example of research on G×E is depicted in Figure 1.1 (Hogben 1933). Cases of G×E are often 
visually displayed by means of a reaction norm graph such as this.1 In this case, different strains 
of the fruit fly Drosophila (low-bar and ultra-bar) were raised at a number of different 
temperatures (x-axis) and then measured for how many eye-facets developed on the flies’ 
compound eyes (y-axis). These phenotypic curves revealed how the different strains of 
Drosophila responded to the varying array of environments.  
 
 
Figure 1.1. Norms of reaction for low-bar and ultra-bar Drosophila strains raised in different 
temperatures. Figure from Hogben (1933, Figure 2). 
 
                                                 
1 For histories of the reaction norm concept, see Griffiths and Tabery (Forthcoming) and Sarkar (1999). 
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Cases of G×E have figured prominently in the history of the nature-nurture debate. For 
most of this history, cases of G×E figured into debates about the group differences between 
populations. With the onset of molecular genetics, however, cases of G×E are now figuring into 
debates about the predispositions of individuals. This introductory chapter is meant to explicate 
this shift and consider how arguments from the older debate might play out in the contemporary 
one. 
 
1.1. Gene-Environment Interaction in the Nature-Nurture Debate 
Quantitative behavioral geneticists traditionally investigate the causes of variation responsible 
for individual differences in a population; they are interested in the relative contributions of 
genetic differences and environmental differences to total phenotypic variation in a population. 
Statistical methodologies, such as the analysis of variance (ANOVA), are then employed in an 
attempt to partition the relative contributions of these factors. These quantitative studies have 
been undertaken for nearly a century now. For example, population geneticist R. A. Fisher, the 
creator of ANOVA, undertook these statistical studies in the early-20th century in order to 
investigate the relative contributions of nature and nurture to physical traits such as stature as 
well as personality traits such as conscientiousness (Fisher 1918, 1924). Agricultural geneticist 
Jay Lush undertook these statistical studies in the mid-20th century in order to investigate the 
relative contributions of nature and nurture to agricultural traits such as milk yield in cattle (Lush 
1937). And educational psychologist Arthur Jensen undertook these statistical studies in the late-
20th century in order to investigate the relative contributions of nature and nurture to general 
intelligence (Jensen 1969). These studies were undertaken as a means to answer questions about 
the causes of group differences between populations. Fisher, a eugenicist, was interested in 
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different social classes in the United Kingdom; Lush was interested in different breeds of cattle; 
and Jensen was interested in different races in the United States (Kevles 1995). If phenotypic 
variation for a trait was largely the result of genetic differences, the inference went, then the 
differences in the trait between classes, cattle, or races could largely be attributed to genetic 
differences. 
 This inference only held up, however, if genetic differences and environmental 
differences fully accounted for the total phenotypic variation in the trait under investigation. In 
statistical terms, the “main effects” of genotype and environment must be “additive.” If the 
genetic variation and the environmental variation were interdependent, then this additivity would 
break down. G×E is precisely this interdependence in genetic variation and environmental 
variation; as a result, it is sometimes referred to as “non-additive variation.” If the total 
phenotypic variation in a trait under investigation results, in part or in whole, from the 
interdependence of genetic variation and environmental variation—that is, from G×E—then 
inferences made about group differences become suspect because total phenotypic variation can 
no longer be attributed to the separate actions of the main effects (Falconer and Mackay 1996).         
 Not surprisingly, then, critics of quantitative behavioral genetics have often pointed to 
G×E as a fundamental problem for those statistical methodologies. British statistician and 
experimental embryologist Lancelot Hogben introduced Figure 1.1 specifically to attack Fisher’s 
statistical techniques for partitioning variation and to undermine the eugenic conclusions about 
class differences inferred from his statistical studies (Hogben 1933). Forty years later, 
evolutionary geneticist Richard Lewontin emphasized the importance of G×E in order to attack 
Jensen’s statistical techniques for partitioning variation and to undermine educational policy 
conclusions about race differences inferred from his statistical studies (Lewontin 1974). 
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Lewontin, like Hogben, provided empirical examples of reaction norms from plant and non-
human animal studies that displayed the divergent phenotypic curves often found in nature 
(Figure 1.2). 
 
 (a)            (b) 
Figure 1.2. Reaction norm graphs. (a) Yarrow genotype, altitude during development (x-axis), 
and plant height in centimeters (y-axis) (Derived from Clausen, Keck, and Hiesey 1948). (b) 
Fruit fly genotype, temperature during development (x-axis), and viability of that genotypic 
group (y-axis) (From Lewontin 1974, Figure 2). 
 
Hogben’s and Lewontin’s arguments were remarkably similar; they both pointed out that 
complex behavioral traits (such as conscientiousness or general intelligence) resulted from 
complicated developmental interactions between genes and the environment, and so variation 
due to G×E should be expected. And if variation in a complex behavioral trait was the result of 
G×E, they argued, then inferences made about the causes of group differences between 
populations as being either genetic or environmental in origin were unfounded. They both were 
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particularly interested in cases of G×E where the reaction norms of different genotypic groups 
crossed each other (as in Figure 1.2a and 1.2b), signifying the fact that the higher-ranking 
genotype in one environment could actually be the lower-ranking genotype in another 
environment.2 Inferences about group differences between populations in unknown or untested 
environments were extremely dangerous, Hogben and Lewontin argued, for a higher-ranking 
genotype in current environments might actually become a lower-ranking genotype in other 
environments.    
 Defenders of the statistical methodologies, however, were unimpressed by the problem. 
Fisher, Lush, and Jensen all dismissed cases of G×E as only a possible, but unproved, 
complication for the evaluation of group differences. It was a possible complication; they readily 
admitted that this non-additive variation did complicate their statistical analyses. But it was also 
an unproved complication; as far as they were concerned, there was insufficient evidence of such 
cases of G×E, and so they put the burden of proof on their critics to show that the possible 
complication was an empirical reality. Hogben pointed Fisher to the Drosophila example from 
Figure 1.1, but Fisher questioned whether this was anything but an exceptional case in the 
natural world. Forty years later, Lewontin pointed Jensen to plant and non-human animal studies 
such as those in Figure 1.2, but Jensen questioned whether the same phenomenon should be 
expected in human populations. For years, defenders and critics argued over whether or not we 
should assume that G×E is common in human populations for complex behavioral traits (Tabery 
2007). Are cases of G×E common in human populations, or are the cases identified by critics 
such as Hogben and Lewontin unusual occurrences?  
 
                                                 
2 I will say more about this cross-over effect and its relationship to cases of G×E that do not involve a cross-over 
effect in the following chapter, where it will be critical to the argument there.  
 5
1.2. Gene-Environment Interaction in the Age of Molecular Genetics 
This question began to be answered by Avshalom Caspi, Terrie Moffitt, and their colleagues 
with a series of empirical studies published between 2002 and 2005.3 Caspi and Moffitt found 
cases of G×E in human populations for three complex human traits. The first study identified a 
case of G×E for a gene controlling neuroenzymatic activity, exposure to childhood maltreatment, 
and the subsequent development of antisocial personality disorder (Caspi et al. 2002). The 
second study identified a case of G×E for a gene controlling serotonin binding activity, exposure 
to stressful life events, and the subsequent development of depression (Caspi et al. 2003). And 
the third study identified a case of G×E for a gene involved in the metabolism of dopamine, 
exposure to cannabis use in adolescents, and the subsequent development of schizophrenia 
(Caspi et al. 2005). Cases of G×E, it seemed, were to be found in human populations.    
 Hogben and Lewontin, in their criticisms of quantitative behavioral genetics, could only 
point to cases of G×E in plant and non-human animal studies, while Caspi and Moffitt published 
a series of empirical studies on G×E in humans. Why? The answer, in short, was the onset of 
molecular genetics. Geneticists have long been able to raise plants and non-human animals with 
identical (or virtually identical) genomes in a varying environment, so as to obtain reaction norm 
data such as that depicted in Figures 1.1 and 1.2. But, for obvious ethical reasons, these same 
studies cannot be performed on humans. Twin studies are one potential method for avoiding this 
problem, but even twins reared apart only provide a geneticist with identical genomes in two 
environments. What if the geneticist is interested in how genomes respond to an array of 
environments involving three or four separate measurements? Cases of triplets or quadruplets 
                                                 
3 I only mention these studies in passing here; the 2003 study and, in particular, the 2002 study will be discussed in 
detail in the subsequent chapters.  
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raised apart and available for genetic research are uncommon, making such studies virtually 
impossible.  
 Caspi and Moffitt’s solution to this problem was to stop investigating what different 
genomes did in different environments and instead investigate what different genes did in 
different environments. With the onset of molecular genetics, particular genes may be identified 
in anyone’s genome, and information about his or her environment along with his or her 
phenotype may also be gathered. So now you and I, even though we are unrelated, could both be 
recruited for a molecular genetics study. Perhaps we share the same variant of the gene 
controlling serotonin binding activity but have experienced different numbers of stressful life 
events. We can now be placed in the same genetic group (presumably with many other study 
participants who also share the same genetic variant) in order to see how individuals with this 
particular gene respond to varying levels of stressful life events, providing the data to construct a 
reaction norm for our genetic group. Our genetic group can also be contrasted with individuals 
from another genetic group, with a different variant of the gene controlling serotonin binding 
activity, in order to compare our genetic group’s response to the varying levels of stressful life 
events with the other genetic group’s response to this same array of environments. 
 Molecular genetics, in addition to opening the door to new genetic methodologies, also 
lends itself to talk of the genetic predispositions of individuals. If it turns out that individuals 
with our variant of the gene controlling serotonin binding activity are more likely to develop 
depression than individuals from the other genetic group across the range of environments tested, 
then should we say that you and I carry a genetic predisposition to depression? If the reaction 
norm for our genetic group is identical to that of the other genetic group, with the only exception 
being that individuals from our genetic group are consistently at increased risk of developing 
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depression, then it does seem to make sense to say our genetic group bears a genetic 
predisposition to depression in the tested environments. But what if the reaction norm for our 
genetic group looks quite different from the reaction norm of the other group? That is, what if 
there is G×E for this particular genetic variant, this array of environments, and depression? And 
what if the reaction norm for our group is so different from the reaction norm of the other group, 
that our group is more likely to develop depression in some environments than the other group 
but less likely to develop depression in other environments? That is, what if the G×E is so 
extreme that there is a cross-over effect like that found in Figure 1.2? As it turns out, this cross-
over effect is precisely what Caspi and Moffitt found in their study of depression. Now who 
bears the genetic predisposition to depression?   
 This thesis is, in part, an effort to bring the arguments of Hogben and Lewontin 
concerning G×E to this new era of molecular genetics. The domain has changed. Hogben and 
Lewontin were interested in debates over group differences between populations; they were 
arguing against unwarranted generalizations made about different classes and different races. 
The debates that I will be considering are over individual predispositions based upon specific 
genes. Still, the basic point made by Hogben and Lewontin—that G×E can sometimes be so 
extreme that the reaction norms cross over—is applicable to the domain of individual 
predispositions. If reaction norms cross over, then we should be wary of generalizations made 
about the genetic basis of group differences. Likewise, if reaction norms cross over, then we 
should be wary of generalizations about the genetic basis of individual predispositions. But what 
can we say beyond this wariness of such generalizations?  
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1.3. Thesis Outline  
The cases of G×E that result in a change of rank identified by Caspi and Moffitt have been 
characterized as if they display an instance of a genetic predisposition to antisocial personality 
disorder, depression, and schizophrenia. The concept of a genetic predisposition to these 
complex traits has shaped the subsequent bioethical discourse concerning the ethical implications 
of testing for the genetic variants involved in those studies.  In chapter 2 I argue that this concept 
of a genetic predisposition fundamentally misconstrues the results of those studies because they 
exhibit the cross-over effect mentioned above. The purpose of chapter 2 is to reveal how the 
concept of a genetic predisposition misconstrues such cases and to then offer up an alternative 
concept—an interactive predisposition—to correct for the conceptual incoherence.  
 Chapters 3 and 4 then explore the implications of this switch from a genetic 
predisposition to an interactive predisposition in the context of the ethical debates surrounding 
genetic testing. In chapter 3, I focus on the ethical questions specifically raised by bioethical 
commentators on the Caspi-Moffitt MAOA study. These commentators have framed the 
discussion as if the ethical questions raised by the MAOA study stem from the fact that Caspi 
and Moffitt identified a genetic predisposition to antisocial personality disorder. But since Caspi 
and Moffitt identified an interactive predisposition to antisocial personality disorder, not a 
genetic predisposition, these ethical questions must be reconceived. I argue there that cases of 
interactive predispositions raise questions quite distinct from the more traditional questions 
raised by genetic predispositions. In particular, I claim that embryonic and fetal screening for 
MAOA activity falls victim to what I call “the myth of pre-environmental prediction” if such 
testing proceeds without considering information about the environmental variable involved in 
the interactive predisposition. I also claim that a mandatory program of newborn screening for 
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MAOA activity must face what I call “the interventionist’s dilemma”; here, the problem is that 
an early intervention program designed to first identify those at risk of developing antisocial 
personality disorder with a genetic test for MAOA activity and then pharmacologically alter that 
MAOA activity will both decrease the risk of developing antisocial personality disorder in some 
individuals who receive the pharmacological treatment while simultaneously increasing the risk 
of developing antisocial personality disorder in other individuals who receive the 
pharmacological treatment. 
 Then, in chapter 4, I expand the discussion of the bioethical implications beyond the 
MAOA study and beyond the ethical questions raised by commentators on that study. I consider 
cases of interactive predispositions for a number of complex traits: asthma, depression, and 
schizophrenia. More specifically, I consider how cases of interactive predispositions should be 
figured into the ongoing debate over providing genetic tests for children at parental requests. The 
bioethical discussion surrounding genetically testing children has focused exclusively on cases of 
genetic determinism (think Huntington’s disease) and genetic predisposition (think hereditary 
breast/ovarian cancer). The purpose of chapter 4 is to draw on the resources developed from 
these bioethical discussions and update them so as to incorporate potential genetic tests for 
interactive predispositions requested by parents for their children.        
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2. FROM A GENETIC PREDISPOSITION TO AN INTERACTIVE PREDISPOSITION: 
RECONCEPTUALIZING GENE-ENVIRONMENT INTERACTION 
 
Abstract. The concept of gene-environment interaction, or G×E, refers to cases where different 
genetic groups respond differently to the same array of environments for a particular phenotypic 
trait. In a widely acclaimed study from 2002, researchers found a case of G×E for a gene 
controlling neuroenzymatic activity (low vs. high), exposure to childhood maltreatment, and the 
development of antisocial personality disorder (ASPD). Cases of G×E are generally 
characterized as evincing a genetic predisposition to the particular trait under investigation; for 
example, individuals with low neuroenzymatic activity are generally characterized as having a 
genetic predisposition to ASPD. This chapter will argue that the concept of a genetic 
predisposition fundamentally misconstrues these cases of G×E. This misconstrual will be 
diagnosed, and then a new concept—interactive predisposition—will be introduced to treat this 
conceptual incoherence.       
 
 
2.1. Introduction 
The concept of gene-environment interaction, or G×E, refers to cases where different genetic 
groups (i.e., two or more populations differentiated based upon a genetic difference) 
phenotypically respond differently to the same array of environments. For example, Avshalom 
Caspi, Terrie Moffitt, and their colleagues found a case of G×E for a gene controlling 
neuroenzymatic activity (low vs. high MAOA activity), exposure to childhood maltreatment 
(none vs. probable vs. severe), and the development of antisocial personality disorder (ASPD) 
(Caspi et al. 2002). MAOA is a metabolic enzyme that inactivates neurotransmitters such as 
dopamine, norepinephrine, and serotonin (Shih, Chen, and Ridd 1999); deficiencies in the 
enzyme have been associated with aggression (Rowe 2001). In the Caspi-Moffitt study, 
childhood maltreatment consisted in physical and sexual abuse. However, other experiences also 
counted as childhood maltreatment: harsh discipline (e.g. parents “smack him or hit him with 
something”), multiple changes in the primary caregiver, and poor mother-child interactions (e.g. 
rough handling of the child, consistent negative affect toward the child, indifference to child’s 
performance). Individuals with none of these incidents in their past were classified as having no 
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experience with childhood maltreatment; individuals with one of these incidents in their past 
were classified as having experience with probable childhood maltreatment; and individuals with 
two or more of these incidents in their past were classified as having experience with severe 
childhood maltreatment.4 As illustrated in Figure 2.1, Caspi and Moffit found that individuals 
with high-MAOA activity gradually increased their risk of developing ASPD as incidents of 
childhood maltreatment increased, whereas individuals with low-MAOA activity drastically 
increased their risk of developing ASPD as incidents of childhood maltreatment increased.  
 
 
Figure 2.1. Reaction norm graph for MAOA activity, childhood maltreatment, and ASPD. (From 
Caspi et al. 2002, Figure 1). 
  
                                                 
4 ‘Probable’, in this case, should be read as ‘moderate’; it is a measure of severity or frequency, not a measure of 
certainty or probability. Also, it will be important to keep the less severe forms of childhood maltreatment in mind 
when we turn to the discussion of the ethical implications of this study in subsequent chapters. 
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 The Caspi-Moffitt results, showing significant G×E for ASPD in a human population, 
were instantly recognized by scientists, the popular press, and academic commentators as a 
landmark achievement in the history of human genetics. Behavioral geneticist Dean Hamer, in a 
review article for Science just two months after Caspi and Moffitt published their results, 
identified the Caspi-Moffitt study as one of three examples paving the way for the future of 
behavioral genetics (Hamer 2002).5 The Economist hailed the results that same week: “The first 
study has just been published showing how a particular gene and a particular environment 
interact to produce violent individuals” (Economist 2002, 71). Bioethicist Erik Parens wrote, “It 
might not be an exaggeration to say that, if replicated, the Caspi-Moffitt MAOA study will turn 
out to have been a watershed event in the history of behavioral genetics” (Parens 2004, S22). 
And legal scholar Robert Stone forecasted, “Although the predictive power of genetics has been 
discussed many times before, the Caspi Study may prove to be the beginning of a new era” 
(Stone 2003, 1559).  
Why such enthusiasm? The enthusiasm can be attributed to two factors. First, as 
mentioned in the introductory chapter, the excitement was, in part, a function of the fact that 
Caspi and Moffitt identified a case of G×E in a human population; one aspect of the nature-
nurture debate hinged on whether or not G×E was present in human populations, and their 
MAOA study offered an empirical answer to that question. Second, the fact that Caspi and 
Moffitt were studying MAOA, in combination with their particular experimental design, is also 
responsible for the attention. It has long been known that deficiencies in the metabolism of 
neurotransmitters were connected with aggressive behavior, but what part genes played in this 
deficiency and what the connection was between gene, neurotransmitter, and aggression 
                                                 
5 The other two studies that Hamer identified as significant involved a neuroimaging study of differences in 
amygdale activity correlated with a genetic difference (Hariri et al.), and an examination of different patterns of gene 
expression for different alleles in a single person (Yan et al.).   
 13
remained a mystery. This connection began to be understood in 1993 with the publication of 
“Abnormal Behavior Associated with a Point Mutation in the Structural Gene for Monoamine 
Oxidase A” (Brunner et al. 1993). Han G. Brunner and his associates found a point mutation in 
the males of a large Dutch family, in which a cytosine base (C) was switched to a thymine base 
(T) in the individuals’ DNA, thus switching the corresponding product from the amino acid 
glutamine (CAG) to a termination codon (TAG). The biochemical result of the point mutation 
was the complete and selective deficiency of MAOA in the 5 affected males of the family. The 
behavioral result was borderline mental retardation along with a tendency towards aggression 
and impulsivity manifested in the form of arson, attempted rape, and exhibitionism. 
The paper, published in Science, attracted much attention and generated intense debate. 
The result, spun into a tale of a gene for aggression, naturally fascinated and outraged many in 
the legal, scientific, and lay communities. Stephen Mobley, a convicted murderer from Georgia, 
who robbed a Domino’s Pizza in 1991, and then executed the store manager with a gun shot to 
the back of his neck, sought genetic testing to determine if he too was MAOA deficient, so that 
his death sentence might be revised, in light of genetically mitigating circumstances, to life in 
prison (Mobley v. State). Legal discussions of this ‘genetic defense’ quickly ensued (Andrews 
2002; Coombs 1999; Denno 1996). Importantly, but less dramatically, the behavioral genetics 
community itself took a step back and reevaluated what it was researching, what it could reliably 
reveal about the causes of complex behaviors, and how that information could be put into 
practical use (Mann 1994). Indeed, Brunner himself, at a conference on the genetics of criminal 
and antisocial behavior, felt the need to deliver a paper on why his study was emphatically not 
the discovery of an aggression gene (Brunner 1996).  
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The Brunner et al. (1993) study raised much interest, but also had limitations. The study 
was confined to a single, Dutch family. There were only 5 affected individuals with the extreme 
metabolic deficiency. And the affected individuals also were afflicted with mental retardation, 
suggesting that the ensuing aggression may have just as easily been a result of the lowered 
intelligence rather than the lowered MAOA. 
The Caspi-Moffitt study, in contrast, drew on the resources available from the Dunedin 
Multidisciplinary Health and Developmental Study in New Zealand, which has been tracking the 
lives of over 1000 New Zealanders from birth (April 1972-March 1973). In addition to 
constituting a large sample, the members also offered a representative sample of the general 
population, thus eliminating the confounding effects of samples drawn from single families or 
multiple families from isolated social or economic brackets. Drawing on this history, Caspi and 
Moffitt determined that 8% of the male participants experienced severe maltreatment between 
the ages of 3 and 11; 28% experienced probable maltreatment between these ages; and 64% 
experienced no maltreatment. All participants were then evaluated for antisocial behavior, based 
on convictions for violent crimes, psychological evaluations, and reports from others who knew 
the participants well. With this environmental and phenotypic information in place, the 
behavioral geneticists then established genotypic information for all the participants, determining 
whether the participants had genotypes associated with low or high MAOA activity. Thus, in 
contrast to the Brunner et al. (1993) study, which investigated a rare and severe genetic 
phenomenon in an isolated population, Caspi and Moffitt investigated a more common, variable, 
and less severe genetic phenomenon in a representative sample. This examination of MAOA 
with a highly valued experimental design is the other reason that the Caspi-Moffitt results 
received so much attention.     
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 It was the significance of Caspi and Moffit’s empirical results that received the wide 
attention. But what was just as significant, though less scrutinized, was the way in which those 
results were conceptualized. Individuals with low-MAOA activity were characterized as having 
a genetic predisposition to ASPD or, because of the correlation between ASPD and violent 
behavior, a genetic predisposition to violence. In his consideration of the familial cycle of abuse, 
Robert Stone wrote, “The Caspi Study demonstrates that, in addition to free will, the difference 
between those who break the cycle of abuse and those who do not turns on the victim’s genetic 
predisposition” (Stone 2003, 1562). David Wasserman titled an article on the bioethical 
implications of the Caspi-Moffitt study, “Is There Value in Identifying Individual Genetic 
Predispositions to Violence?” (Wasserman 2004). Crucially, and as will be explored in more 
detail in subsequent chapters, this concept of a genetic predisposition has framed the ethical and 
legal reflections on this case of G×E. Jonathan Moreno, for instance, pointed to the Caspi-Moffitt 
study and advised, “If [MAOA] or other neurotransmitters are roughly associated with socially 
offensive behaviour, even under less extreme environmental insults, they could be brought into 
the controversy over preimplantation genetic diagnosis. Prospective parents might therefore test 
embryos for the MAOA marker before implantation to avoid giving birth to a child with this 
particular potential for criminality” (Moreno 2003, 151). And, considering the possible 
implications of the Caspi-Moffitt study on the criminal justice system, Paul Appelbaum asked, 
“Should genetic propensities mitigate punishment for criminal behavior?” (Appelbaum 2005, 
26). 
 The thesis of this chapter will be that this concept of a genetic predisposition 
fundamentally misconstrues cases of G×E such as that found in the Caspi-Moffitt study. In turn, 
the ethical discussions of a “genetic predisposition to violence” have been equally misconceived. 
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In the next section of this chapter, I focus on exposing how the concept of a genetic 
predisposition fundamentally misconstrues these cases of G×E. With that diagnosis made, I then 
offer in section 2.3 a remedy for the conceptual incoherence by introducing a new concept for 
these cases of G×E—interactive predisposition. The conceptual shift from a genetic 
predisposition to an interactive predisposition will pave the way for the subsequent chapters in 
which I explore how this shift reframes questions concerning the incorporation of research on 
G×E into ethical discussions of screening embryos, fetuses, and newborns for an interactive 
predisposition to ASPD (chapter 3), or testing children for interactive predispositions to a wider 
variety of complex traits, such as asthma, depression, and schizophrenia (chapter 4).6        
  
2.2. G×E and the Concept of a Genetic Predisposition 
As described in the introduction, cases of G×E are generally characterized in terms of a genetic 
predisposition to the trait under investigation; for example, individuals with low-MAOA activity 
from the Caspi-Moffitt study are characterized as having a genetic predisposition to violence. 
The goal of this section is to convey how this concept fundamentally misconstrues cases of G×E. 
Understanding this misconstrual begins by recognizing the fact that cases of G×E come in two 
forms: those resulting in a change in scale, and those resulting in a change in rank (Lynch and 
Walsh 1997). The traditional concept of a genetic predisposition, I will argue, is appropriately 
applied only to cases of a change in scale; the misconstrual arises when it is also applied to cases 
of a change in rank.  
 
                                                 
6 The grouping of embryos, fetuses, and newborns here should not be interpreted as an implicit argument for the 
moral equivalence of humans at these developmental stages. Rather, it is a practical grouping; the commentators 
who I will discuss in chapter 3 have raised the prospect of screening humans at each of these developmental stages. 
As we will see, the group will be divided between pre-implantation genetic diagnosis and fetal screening, on the one 
hand, and newborn screening, on the other hand.  
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2.2.1. A Change in Scale  
An instance of G×E resulting only in a change of scale refers to cases where different genetic 
groups respond differently to the same array of environments, but that difference in phenotypic 
response does not alter the fact that the higher-ranking group maintains that higher ranking 
across all tested environments (Lynch and Walsh 1997). An example will help to display this 
phenomenon, so consider the reaction norm graph in Figure 2.2. This is a hypothetical, modified 
version of the original graph from the Caspi-Moffitt study. Everything in Figure 2.2 is identical 
to the original graph except that the high-MAOA group has been lowered by 0.25 on the 
antisocial behavior index for each environment. That is, the high-MAOA group has been 
bumped down on the y-axis. Now the low-MAOA group maintains its higher ranking on the 
antisocial behavior index in each of the tested environments. This is still a case of G×E because 
the two groups do still respond to the array of environments quite differently, but all that has 
changed is the scale of the difference between the two groups in the different environments. That 
is, the two reaction norms are not parallel; the high-MAOA group increases on the antisocial 
behavior index as incidents of childhood maltreatment increase but only gradually in comparison 
to the low-MAOA group, which increases on the antisocial behavior index quite drastically as 
incidents of childhood maltreatment increase.  
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 Figure 2.2. Hypothetical reaction norm graph for MAOA activity, childhood maltreatment, and 
ASPD. 
 
 To begin evaluating the appropriateness of the concept of genetic predisposition as 
applied to cases of G×E, a definition of this concept must first be afforded. “Genetic 
predisposition” may be defined as follows: 
Genetic Predisposition: The presence of a genetic difference between various groups 
consistently increases the probability of individuals from one group, in comparison to 
individuals from the other group(s), developing a particular phenotypic trait regardless of 
the tested environmental conditions of development. 
 
Note the relational nature of this definition. Members of any group may be susceptible to 
developing the particular phenotypic trait under investigation if exposed to the environmental 
stressor. But attaching “genetic” to “predisposition” is only appropriate if it is the genetic 
difference that consistently increases the probability of individuals from one group developing 
the phenotypic trait relative to individuals from the other group(s). Also note the fact that the 
relative predisposition is only justifiably applicable within the tested environmental conditions of 
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development. Under unknown or untested environmental conditions of development, the 
relationship between the groups might change quite drastically. Thus, one cannot assume that 
just because individuals in a particular group are relatively genetically predisposed to a particular 
phenotypic trait under known environmental conditions of development that this relationship will 
hold true under any environmental conditions of development. 
 Cases of G×E resulting in a change of scale may be appropriately characterized with the 
concept of a genetic predisposition as defined above. Consider the hypothetical Caspi-Moffitt 
case graphed in Figure 2.2: in every tested environment (none, probable, and severe childhood 
maltreatment), individuals in the low-MAOA group maintained their relatively elevated risk for 
ASPD; moreover, the slope of the low-MAOA group was much steeper than that of the high-
MAOA group as the instances of childhood maltreatment increased. What “genetic 
predisposition” implied in this case, then, was that the presence of the genetic difference between 
the two groups consistently put individuals from the low-MAOA group at an increased risk of 
developing ASPD relative to the individuals from the high-MAOA group. And again, notice that 
the account here was necessarily relational. As the instances of childhood maltreatment 
increased, both groups significantly increased on the antisocial behavior index. In statistical 
terminology, the environmental variable was a statistically significant main effect. Thus, 
individuals from both genetic groups were susceptible to developing ASPD in the presence of 
childhood maltreatment. But there still remained a consistent phenotypic difference between the 
genetic groups in each tested environment, and this difference itself increased drastically as the 
instances of childhood maltreatment increased. There was a change between the groups across 
the different environments, but it was only a change in scale. Or, for an empirical example, 
consider the BRCA1 and BRCA2 alleles responsible for increased risk of breast and ovarian 
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cancers. A ‘genetic predisposition to breast/ovarian cancer’ is appropriately linked with these 
alleles, since bearing these alleles consistently increases the risk of developing breast/ovarian 
cancer in the known environments.  
 
2.2.2. A Change in Rank  
But notice that the above account is decidedly not what occurs in the actual Caspi-Moffitt study. 
Caspi and Moffitt’s MAOA study is instead an instance of G×E resulting in a change of rank. An 
instance of G×E resulting in a change of rank refers to cases where different genetic groups 
respond differently to the same array of environments, and that difference in phenotypic response 
is so extreme that the higher-ranking group in one environment becomes the lower-ranking 
group in a different environment (Lynch and Walsh 1997). Notice that this is precisely what we 
find in the actual reaction norms for the Caspi-Moffitt study’s low- and high-MAOA groups 
graphed above in Figure 2.1. In the environments with probable and severe childhood 
maltreatment, the low-MAOA group did in fact score higher on the antisocial behavior index 
than the high-MAOA group. However, in the environment with no childhood maltreatment the 
low-MAOA group actually scored lower than the high-MAOA group on the index. Importantly, 
this case of G×E did not display the consistency in the relationship between the two groups 
across all of the tested environments, which was described in the hypothetical case of a change in 
scale described above. 
 The original Caspi-Moffitt study has now been replicated several times. In 2004, a group 
of behavioral geneticists at the University of Virginia investigated the phenomenon in a new 
population from the United States (Foley et al. 2004). Their replication was slightly altered. They 
still differentiated genetic groups based on low- vs. high-MAOA activity; however, they instead 
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tracked childhood conduct disorder (CD), the childhood equivalent of ASPD. Nevertheless, their 
results were consistent with the change in rank, as can be seen in Figure 2.3. More recently, 
Caspi and Moffitt themselves participated in a replication study with a new population from 
Britain (Kim-Cohen et al. 2006). And again, their results were consistent with the change in 
rank. There have also been two failures to replicate the interaction effect (Haberstick et al. 2005; 
Young et al. 2006); however, the study by Kim-Cohen et al. (2006) also included a meta-analysis 
of the data from the multiple sources, and the interaction effect was significant. 
    
 
Figure 2.3. Reaction norm graph for MAOA activity, childhood adversity, and conduct disorder. 
(From Foley et al. 2004). 
 
 Interestingly, while the reaction norms in both Figures 2.1 and 2.3 do clearly cross each 
other (or change in rank), the difference between the two genetic groups in environments with no 
childhood maltreatment/adversity is not statistically significant. In other words, the gap between 
the two groups could conceivably be the result of chance. If the gap really is due to chance and 
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there is no actual difference between these two genetic groups, then my analysis in this chapter is 
inapplicable to the case of MAOA, childhood maltreatment, and the development of ASPD, 
since the case would be reduced to one of a change in scale. To be clear, it would not mean that 
my analysis of the inappropriateness of the concept of a genetic predisposition to cases of G×E 
resulting in a change of rank is mistaken, but it would mean that the MAOA case does not fall 
within this category. However, there is good reason to attribute the lack of significance to a 
different explanation—insufficient sample size. It is notoriously difficult to detect interaction 
effects without very large sample sizes. Starting with the Caspi-Moffitt study and continuing 
with the multiple replications, the results of these studies repeatedly display the change in rank 
for the genetic groups across the array of environments. However, these studies generally include 
only several hundred participants with only a proportion in each environment, providing 
relatively little statistical power to tease apart a genetic difference in the separate environments. 
Foley et al., in the discussion of their results, reached a similar conclusion: “An interaction 
without a significant main effect of genotype results in a crossing-over or reordering of risk 
among groups contingent on environmental exposure. In this case, risk associated with a specific 
genotype differs qualitatively in association with different environments. Variation in exposure 
to environmental risks reorders genotypic effects. Our data are consistent with [this] explanation, 
but a larger study is required to definitively address this possibility” (Foley et al. 2004, 742). It 
seems prudent, then, to assume that the change in rank is a very real possibility. Such prudence is 
especially justified when we remember that the identification of these cases of G×E in humans is 
a fairly young enterprise, while the identification of these cases of G×E in plants and non-human 
animals has been quite common in the history of genetics. As mentioned in chapter 1, Lewontin 
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pointed to two cases of G×E that resulted in a change of rank in the context of the IQ 
Controversy—one for the plant yarrow and one for the fruit fly Drosophila.  
 With regard to the human study by Caspi and Moffitt, ignoring the very real possibility 
that their results reflect at true change in rank and not just chance, would have a terrible impact 
on efforts to utilize this data for purposes of genetic testing any population—embryos, fetuses, 
newborns, or children. The relevance of the Caspi-Moffitt results for genetic testing will be the 
topic that I take up in the subsequent chapters. In the meantime, I will proceed in this chapter as 
if the change in rank is real for the MAOA case and continue to diagnose the fundamental 
misconstrual that arises from characterizing it with the concept of a genetic predisposition.  
 The concept of genetic predisposition, as defined above, captures cases where a genetic 
difference between groups consistently increases the probability of individuals from one of these 
groups developing a phenotypic trait regardless of the tested environmental conditions 
experienced during development. But in the Caspi-Moffitt study the environmental conditions 
were crucial for assessing the relationship between the low-MAOA and the high-MAOA groups 
with regard to risk of developing ASPD. Prior to an individual actual experiencing—or otherwise 
determining the environmental conditions (i.e., the degree of childhood maltreatment) that the 
individual faces, there is simply no way to assess whether an individual with low-MAOA 
activity will be more or less prone to developing ASPD than an individual with high-MAOA 
activity. The low-MAOA individual is less likely to develop ASPD in environments with no 
childhood maltreatment, while s/he is more likely to develop ASPD in environments with 
probable and severe childhood maltreatment. Employing the concept of a genetic predisposition 
to ASPD when the environmental conditions of development are unknown, we are forced 
incoherently to say that individuals in the low-MAOA group are simultaneously more prone to 
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developing ASPD and, at the same time, less prone to developing ASPD. In short, the concept of 
a genetic predisposition fundamentally misconstrues these cases of G×E resulting in a change of 
rank because it leads to this incoherent result.    
 
2.3. G×E and the Concept of an Interactive Predisposition 
Several bioethicists have rightly stressed the need to promote conceptual clarity concerning G×E 
research and behavioral genetic research more generally in light of the looming social, ethical 
and legal implications of this research. Parens warned, “…the consequences of new information 
about genetic influences on the sorts of people we are will to a large extent be determined by the 
interpretations we arrive at in the course of our public conversation” (Parens 2004, S27). He thus 
called for “conceptual tools—basic concepts and distinctions” that will guide this public 
conversation (ibid, S30). Likewise, Richard Sharp wrote, “Clarifying these emerging areas of 
concern is an important step in minimizing the potential harms of deciphering complex gene-
environment interactions” (Sharp 2001, 146). Suggestions such as these should be heeded, for 
there is already an indication that G×E results can be quickly morphed into interpretations of 
‘genes for’ complex behavioral traits, reverting to a naïve genetic essentialism (Dreyfuss and 
Nelkin 1992). Parens has pointed to alarming distillations of the Caspi-Moffitt study in the 
popular press. “That behavioral geneticists are studying such interactions is good news,” Parens 
reminded his readers; however, “the bad news is that the MAOA study was the subject of a piece 
in Popular Mechanics titled ‘Criminal Genes.’ The piece in Time about the MAOA study was 
entitled, ‘The Search for the Murder Gene.’ Although both reporters told subtler stories than the 
titles announced, the idea that some kids are simply born bad persists. Even though the Caspi and 
Moffitt MAOA study is about the interaction between genes and child abuse, the story titles in 
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the popular press suggest that genes ‘cause’ criminality” (Parens 2004, S8). And the Economist, 
though not encouraging a ‘gene for’ interpretation of the results of the Caspi-Moffitt study, did 
warn of the ‘gene for’ interpretation that could easily follow: “Low-activity promoter regions 
could be regarded as ‘genes for violence’ that need a violent context to be expressed. That might 
make sense in evolutionary terms, since a child brought up in violent surroundings will probably 
live in a violent world as an adult and might therefore need to employ violence to thrive. On the 
other hand, high-activity promoter regions could be regarded as genes for the suppression of 
violence” (Economist 2002, 71).  
 Should we really be surprised that the Caspi-Moffitt study has been morphed into a story 
about “Criminal Genes” when the concept of a genetic predisposition to violence has been used 
to characterize the results? With the concept of a genetic predisposition to violence, the rigidly 
deterministic nature of the genetic element may have been abandoned, but it is still the “genetic” 
that is in the driver’s seat. That is, it is still the “genetic” that is doing the predisposing. Or, more 
accurately, it is still the genetic difference that is associated with the difference in relative 
predisposition. It may be inappropriate to title articles in the popular press about the Caspi-
Moffitt study “Criminal Genes” or “The Search for the Murder Gene,” but what about “Criminal 
Susceptibility Genes” or “The Search for the Murder-Liability Gene”? Would these alternatives 
be acceptable? If one were entitled to employ the concept of a genetic predisposition to violence, 
then I do not see how one could criticize such distillations. But when we realize that the Caspi-
Moffitt study was a case of G×E resulting in a change of rank, then we clearly see that even the 
non-deterministic alternative titles are misleading. Which variant of the gene associated with 
MAOA activity is the criminal susceptibility gene—low or high? Which variant of the gene 
associated with MAOA activity is the murder-liability gene—low or high? The lesson of the last 
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section was that these questions are meaningless unless the environmental conditions are 
specified. 
 I am in agreement with Parens’s and Sharp’s diagnoses. Conceptual clarity is exactly 
what is needed to properly discuss instances of G×E and convey the ethical and legal 
implications of this phenomenon. In this spirit, I suggest jettisoning the concept of a genetic 
predisposition from the discussions of G×E that result in a change of rank. As Parens suggested, 
“conceptual tools” are needed here. A new concept is needed to capture the different, unique 
relationship between gene, environment, and phenotype found in these cases and to set this 
relationship (and the implications of this relationship) apart from cases of genetic predisposition 
or genetic determinism. I propose employing the concept of an interactive predisposition for 
such cases. “Interactive predisposition” may be defined as: 
Interactive Predisposition: The presence of a genetic difference between various groups 
can either increase or decrease the probability of individuals from one group, in 
comparison to individuals from the other group(s), developing a particular phenotypic 
trait depending on the environmental conditions experienced during development. 
 
A genetic predisposition is relational in one sense, whereas an interactive predisposition is 
relational in two senses. Like the concept of a genetic predisposition, the concept of an 
interactive predisposition is relational in the sense that the probability of individuals from one 
group developing the phenotypic trait under investigation is always considered in comparison to 
individuals from the other group(s) developing the phenotypic trait. For a genetic predisposition, 
however, that relation between the groups maintains a consistency (between which is higher and 
which is lower ranking) across all tested environments, whereas this is not the case for an 
interactive predisposition. For an interactive predisposition, the relation between the groups is 
itself relative to the environmental conditions experienced during development.  
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 Before concluding this chapter focused on the conceptualization of G×E, a few words 
should be said about the relationship between the concept of an interactive predisposition and 
already existing concepts. Why not, for instance, just use the already existing concept of genetic 
sensitivity to describe cases of G×E resulting in a change of rank? Introduced by Kenneth 
Kendler and Lindon Eaves (1986), “genetic sensitivity to the environment” has become the 
standard phrase to apply to cases of G×E. Notice, though, the difference between the concepts of 
genetic predisposition and genetic sensitivity. These concepts are capturing quite different 
relationships. Predisposition refers to the relationship between a gene and the probabilistic 
development of a phenotypic trait. Sensitivity, in contrast, refers to the intimate relationship 
between a gene and the environmental conditions experienced by an individual during 
development. In short, predisposition refers to the gene-phenotype relationship, while sensitivity 
refers to the gene-environment relationship. Likewise, the cognates of genetic predisposition, 
such as genetic propensity, genetic liability, and genetic risk, refer to the gene-phenotype 
relationship, while the cognates of genetic sensitivity, such as genetic vulnerability and genetic 
susceptibility (to environmental stressors), refer to the gene-environment relationship. Genetic 
sensitivity, then, is a general concept that captures all cases where the environment moderates 
gene action. That is, the concept of genetic sensitivity is applicable to all cases of G×E, be they 
changes in scale or changes in rank.  
 However, in capturing the general gene-environment relationship, the concept of genetic 
sensitivity cannot distinguish between the different instantiations of G×E (change in scale vs. 
change in rank). The concept of a genetic predisposition (or propensity, liability, or risk) is 
applicable to cases of G×E resulting in a change of scale; it incorporates the implied genetic 
sensitivity of all cases of G×E, but it also specifies the way in which that general gene-
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environment relationship manifests itself in the form of the phenotype for different groups. That 
is, the gene-environment relationship for one group (i.e., its genetic sensitivity) consistently 
increases the probability (in comparison to the other group(s)) of developing the phenotypic trait 
under investigation regardless of the environmental conditions of development. The concept of 
an interactive predisposition is applicable to cases of G×E resulting in a change of rank. Like 
genetic predisposition, interactive predisposition also incorporates the implied genetic sensitivity 
of all cases of G×E, but it also specifies the way in which that general gene-environment 
relationship manifests itself in the form of the phenotype for different groups. That is, the gene-
environment relationship for one group (i.e, its genetic sensitivity) can either increase or 
decrease the probability (in comparison to the other group(s)) of developing the phenotypic trait 
under investigation depending on the environmental conditions experienced during development. 
The relationship between cases of G×E and the concepts of genetic sensitivity, genetic 
predisposition, and interactive predisposition is diagrammed in Figure 2.5. Within this figure, I 
have represented instances of G×E resulting in a change of scale and instances of G×E resulting 
in a change of rank both occupying equal portions of all cases of G×E; however, it is of course 
an empirical question as to which of these is more common in nature. 
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 Figure 2.4. The relationship between cases of G×E and the concepts of genetic sensitivity, 
genetic predisposition, and interactive predisposition. 
 
2.4. Conclusion 
This chapter examined how cases of G×E are conceptualized. Cases of G×E, such as that found 
in the Caspi-Moffitt study, are generally characterized as representing a genetic predisposition to 
the trait under investigation. I argued that this concept of a genetic predisposition, while 
appropriate for cases of G×E resulting in a change of scale, fundamentally misconstrues cases of 
G×E resulting in a change of rank. For cases of G×E resulting in a change of rank, individuals 
are incoherently understood to be simultaneously more and less genetically predisposed to the 
trait under investigation. With this diagnosis made, I then offered a remedy for this conceptual 
incoherence—a new concept for cases of G×E resulting in a change of rank: interactive 
predisposition.    
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 This conceptual shift from a genetic predisposition to an interactive predisposition paves 
the way for investigating how this shift reframes the ethical discussions of a G×E for 
neuroenzymatic activity, childhood maltreatment, and ASPD. Since the publication of the Caspi-
Moffitt study, ethical discussions of the implications of their results have been framed in terms of 
individuals having a genetic predisposition to ASPD and violence. The conclusion of this 
chapter, however, has been that employing this concept of a genetic predisposition 
fundamentally misconstrues the results of the Caspi-Moffitt study, since it is an instance of a 
G×E resulting in a change of rank. It is time, then, to investigate how the shift from a genetic 
predisposition to an interactive predisposition translates into a shift in how the ethical 
implications of the Caspi-Moffitt study should be understood. It is to this task that I now turn.  
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3. GENETIC SCREENING FOR AN INTERACTIVE PREDISPOSITION: 
THE MYTH OF PRE-ENVIRONMENTAL PREDICTION AND THE 
INTERVENTIONIST’S DILEMMA 
 
Abstract. Antisocial Personality Disorder (ASPD) takes a significant toll on those who suffer 
from the disorder and on those who are forced for whatever reason to interact with those who 
suffer from the disorder. So it is not surprising that efforts are made to prevent the development 
of ASPD by predicting who is at risk of developing ASPD and intervening on those variables 
deemed responsible for this development. The 2002 study by Avshalom Caspi, Terrie Moffitt, 
and their colleagues on a gene controlling MAOA activity (low vs. high), childhood 
maltreatment, and ASPD has been highlighted by commentators as a possible empirical basis for 
preventing ASPD. The thought is to identify those predicted to be “genetically predisposed to 
ASPD” (i.e., the low-MAOA individuals) either through preimplantation diagnosis, fetal 
screening, or newborn screening. Then, parents could avoid giving birth to low-MAOA children 
by selecting against low-MAOA embryos and fetuses. And states could identify low-MAOA 
newborns and implement an early intervention program to provide an “MAOA boost” to those in 
need. The problem with these analyses is that they mistakenly assume that Caspi and Moffitt 
identified an instance of a genetic predisposition when in fact they identified an instance of an 
interactive predisposition. Screening for interactive predispositions raises a series of ethical 
questions that are distinct from the standard ethical questions raised by screening for genetic 
predispositions. This chapter will explore these ethical questions. Screening embryos or fetuses 
with an eye towards selecting against low-MAOA individuals will be shown to suffer from the 
trappings of the myth of pre-environmental prediction. Screening newborns with an eye towards 
early intervention will be shown to face the interventionist’s dilemma.   
 
 
3.1. Introduction 
Antisocial Personality Disorder (ASPD) is the clinical term for sociopathy. According to the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), ASPD is defined by a 
pervasive pattern of disregard for and violation of the rights of others. It is diagnosed in an 
individual when there is evidence of three or more of the following: (1) failure to conform to 
social norms with respect to lawful behaviors as indicated by repeatedly performing acts that are 
grounds for arrest, (2) deceitfulness, as indicated by repeated lying, use of aliases, or conning 
others for personal profit or pleasure, (3) impulsivity or failure to plan ahead, (4) irritability and 
aggressiveness, as indicated by repeated physical fights or assaults, (5) reckless disregard for 
safety of self or others, (6) consistent irresponsibility, as indicated by repeated failure to sustain 
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steady work or honor financial obligations, and (7) lack of remorse, as indicated by being 
indifferent to or rationalizing having hurt, mistreated, or stolen from another (American 
Psychiatric Association 2000).7   
ASPD, which affects roughly 3% of males and 1% of females (Fishbein 2000a), takes a 
significant toll on those who suffer from the disorder and on those who are forced for whatever 
reason to interact with those who suffer from the disorder. In disregarding and violating the 
rights of others, those with ASPD regularly engage in actions that are deemed inappropriate and 
potentially illegal by the society in which they live; such actions, in turn, lead to broken 
relationships, and possibly to incarceration or a more extreme punishment. Friends and family 
members of those with ASPD must interact with and perhaps even care for these individuals 
despite the fact that they are in constant threat of being lied to, manipulated, or physically 
abused. Members of society in which those with ASPD live also must co-exist with these 
individuals; they are also in danger of having their rights violated, and they are responsible for 
funding the state’s criminal justice system which captures, judges, and incarcerates these 
individuals, as well as the state’s mental health institutions which also often house them.   
 So it is not surprising that efforts are made to prevent the development of ASPD 
(Fishbein 2000a; McCord and Tremblay 1992; Reid and Eddy 1997). These preventative 
strategies generally consist in the prediction of those individuals deemed at risk of developing 
ASPD and the intervention on those factors deemed pertinent to this development. For better or 
worse, the prediction of those who are at risk of developing ASPD is thoroughly probabilistic. 
Quantitative behavioral genetic studies reveal a heritable element for the disorder (Carey and 
Goldman 1997; Goldman and Fishbein 2000; McGuffin and Thapur 1998). But there are no 
                                                 
7 A personality disorder like ASPD is classified as Axis II of the DSM-IV-TR, as oppose to clinical/mental disorders 
such as schizophrenia or posttraumatic stress disorder, which are classified as Axis I.  
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single genes that deterministically ensure the development of ASPD (Carey 1996; Ridenour 
2000); candidate genes have been identified, but most individuals with these genes still do not 
develop ASPD (Goldman 1996). There are also no natural environments that deterministically 
ensure the development of ASPD. Certain environmental variables, like childhood maltreatment 
or coercive parenting, do account for a significant portion of variation for ASPD in a population, 
but still most children who are maltreated or coerced do not develop ASPD (Reid, Patterson, and 
Snyder 2002).  
 What made the study by Avshalom Caspi, Terrie Moffitt, and their colleagues so 
exciting, then, was the fact that they found a particular genetic variable and a particular 
environmental variable which, when joined, led to almost all individuals developing ASPD 
(Caspi et al. 2002). More specifically as shown in Figure 3.1, Caspi and Moffitt found that 85% 
of the individuals in their sample who both had low-MAOA activity and experienced severe 
childhood maltreatment (see highlighted portion on Figure) subsequently engaged in antisocial 
behavior. To relate this finding to the question of societal impact, Caspi and Moffitt found that, 
while only 12% of the sample fell into this low/severe sub-group, they accounted for a full 44% 
of the violent convictions of the entire study population.   
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 Figure 3.1. Reaction norm graph for MAOA activity, childhood maltreatment, and ASPD with 
low/severe sub-group highlighted. (Modified from Caspi et al. 2002, Figure 1). 
 
 In light of the striking results from the Caspi-Moffitt study, how might their findings be 
incorporated into the ethical discussions of genetic screening for a complex behavioral trait? 
Commentators on the Caspi-Moffitt study have pointed to two potential venues for such a 
genetic test: (a) parents interested in screening either embryos or fetuses with an eye toward 
implantation or termination, and (b) states interested in a policy of mandatory newborn screening 
with an eye toward prediction and intervention. 
 “I’ve taken the liberty of eradicating any potentially prejudicial conditions: premature 
baldness, myopia, alcoholism and addictive susceptibility, a propensity for violence, obesity, 
etcetera” (emphasis added). This line was spoken by a genetic counselor portrayed in the “not-
too-distant” future in the 1997 movie GATTACA. In this fictional future, parents can choose 
either to engage in a “faith-based” pregnancy and leave their child’s phenotypic future to chance, 
or to visit a genetic counselor such as the one mentioned above and select which genes he or she 
 35
will have. How distant is this “not-too-distant” future? Perhaps surprisingly, steps are already 
being taken to bring this future into the present. Neuromark, a Colorado-based company founded 
in 2001 by CEO Kim Bechthold, is currently seeking FDA approval to make available to the 
public a genetic test for the gene controlling MAOA activity—the gene which figured so 
crucially in the Caspi-Moffitt study. So, rather than considering some abstract future, we are now 
in a position to ask very real questions with looming answers: Will genetic counselors soon offer 
prospective parents the choice between a child with low- or high-MAOA activity? Will a state 
soon be able to utilize the results of the Caspi-Moffitt study to predict and intervene on those 
with an alleged propensity for violence?     
 The purpose of this chapter is to address these questions that have been raised by 
commentators by drawing on the lesson of chapter 2 and then exploring the ethical questions that 
are raised by screening for interactive predispositions rather than genetic predispositions. The 
moral will be that screening for interactive predispositions raises a series of ethical questions that 
are distinct from those raised by screening for genetic predispositions. Attempts to appropriate 
the results from the Caspi-Moffitt study for preimplantation or fetal diagnosis will suffer from 
what I call the myth of pre-environmental prediction in the next section. Attempts to appropriate 
the results from the Caspi-Moffitt study in order to implement a policy of mandatory newborn 
screening will have to face what I discuss as the interventionist’s dilemma in section 3.3.  
 
3.2. Preimplantation Genetic Diagnosis, Fetal Screening, and the Myth of Pre-
Environmental Prediction 
The preimplantation genetic diagnosis of embryos and the genetic screening of fetuses both raise 
interesting ethical questions. Is the utilization of genetic information to determine who should 
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and should not be born a reversion to the negative eugenic practices of the early-20th century 
(Paul 1994)? The utilization of genetic information in order to select against potential humans 
with undesirable traits certainly smacks of eugenic motivations (Duster 1990). But now it is the 
parents of embryos and fetuses doing the selecting, not the state, so if the threat of eugenics is 
real, it is certainly of a different sort (Buchanan, Brock, Daniels, and Wikler 2000; Kitcher 
1996). The purpose of this section will not be to carve out a position on this broad social debate. 
Rather, the purpose will be to assess how the results of the Caspi-Moffitt study are being and 
should be incorporated into this broad social debate. That is, the question to be addressed is the 
following: What precisely are the implications of the Caspi-Moffitt study for the ethical 
discussions of preimplantation genetic diagnosis and fetal screening? The argument will be that 
these implications are being misconceived by commentators who misunderstand the Caspi-
Moffitt study to reveal a genetic predisposition to ASPD or violence, when instead the Caspi-
Moffitt study reveals an interactive predisposition. Screening for an interactive predisposition 
raises ethical questions that are distinct from those raised by screening for a genetic 
predisposition. 
 Jonathan Moreno, in his discussion of the Caspi-Moffitt study, warns, “if [MAOA] or 
other neurotransmitters are roughly associated with socially offensive behaviour, even under less 
extreme environmental insults, they could be brought into the controversy over preimplantation 
genetic diagnosis. Prospective parents might therefore test embryos for the MAOA marker 
before implantation to avoid giving birth to a child with this particular potential for criminality” 
(Moreno 2003, 151). And David Wasserman, asking “Is There Value in Identifying Individual 
Genetic Predispositions to Violence?”, introduces his article with a similar question. Since Caspi 
and Moffitt found that the 12% of their research participants who were both maltreated and 
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carrying the gene for low-MAOA activity accounted for 44% of all convictions for violent 
crimes, Wasserman wonders, “what if we could identify some individuals in that 12% not only at 
birth, but in utero, or before implantation?” (Wasserman 2004, 24). Wasserman warns against 
using such information to selectively implant, abort, or intervene on those with a “violence 
propensity”; for instance, Wasserman argues that a society may want to have these low-MAOA, 
violence-prone individuals around: “maybe Kitty Genovese, who was murdered on a New York 
City street while more than thirty witnesses did nothing would have been more likely to survive 
her attack if there were more low MAOA men on her block” (ibid, 29). 
 It is important to note that Moreno and Wasserman do not advocate utilizing the results 
of the Caspi-Moffitt study for the purposes of preimplantation genetic diagnosis or fetal 
screening. Rather, they are simply drawing attention to the ethical questions raised by the 
possibility that these results could be utilized for screening purposes because it may seem 
reasonable to select against low-MAOA individuals with a genetic predisposition (or 
“propensity” for Moreno and Wasserman) to violence. My claim is that, by framing these ethical 
questions in terms of the concept of a genetic predisposition to violence, they have both fallen 
trap to the myth of pre-environmental prediction and thereby misconceived the ethical questions 
raised by the Caspi-Moffitt study. 
 For example, should parents want to screen their embryos or their fetuses for the gene 
controlling MAOA activity in order to identify and select against those embryos or fetuses with 
low-MAOA activity, as Moreno warns? Only if the parents are already intending to maltreat 
their children! That is, if the children are not likely to experience childhood maltreatment, then it 
is in fact the low-MAOA embryos or fetuses that are less likely than the high-MAOA embryos or 
fetuses to develop into adults with ASPD. Would Kitty Genovese, as Wasserman wonders, have 
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been better off if there were more low-MAOA men living on her block? Only if we assume that 
those men experienced childhood maltreatment. That is, if the men on her block had not 
experienced childhood maltreatment, then it would have been the high-MAOA men who were 
more likely to develop ASPD.8 Slipping into the myth of pre-environmental prediction arises 
when one forgets that Caspi and Moffitt found an instance of an interactive predisposition and 
assumes that the genetic information alone is enough to label the low-MAOA individuals 
“genetically predisposed to ASPD or violence.”  
 Importantly, once we keep the myth of pre-environmental prediction in sight and avoid 
slipping into its trappings, it does not follow that the ethical questions raised by genetic screening 
disappear. Instead, a new series of questions arise. For example, if parents can reasonably predict 
that their children will not experience childhood maltreatment, then it would be the high-MAOA 
embryos or fetuses that will be selected against if the parents wanted to protect against ASPD. 
This is because, in the environments with no childhood maltreatment, Caspi and Moffitt found 
the high-MAOA sub-group to have the elevated risk of developing ASPD. Consider parents in 
the “not-too-distant” future who visit their genetic counselor and decide that they want to select 
against the high-MAOA genetic variant. Should this request be predicated on proof of no history 
of engaging in childhood maltreatment? How would a genetic counselor secure this information? 
Or what about parents who do have a history of maltreating children but who have now turned 
over a new leaf? Should they now be allowed to select against the high-MAOA genetic variant as 
                                                 
8 In fact, the MAOA status of the men on Ms. Genovese’s block would most likely have had little impact on her 
survival regardless of whether or not those men experienced childhood maltreatment. The kind of violence that 
individuals with ASPD engage in generally amounts to physical assault and rape, not the kind of violence that 
amounts to intervening in a situation to save a victim. Indeed, the MAOA status of the men on her block (along with 
the environmental conditions of development) would be more likely correlated with the person who murdered her 
rather than with who might have saved her. The danger of slipping from MAOA status to take-charge-kind-of-guy 
comes from both incorrectly equating ASPD with a propensity for violence and equating all types of violent action 
(i.e., assuming violence, is violence, is violence).    
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well, or is the risk of childhood maltreatment and then the subsequent risk of developing ASPD 
just too high for the low-MAOA child-to-be?  
This question of confirming or disconfirming childhood maltreatment is complicated 
when we remember that, in the Caspi-Moffitt study, childhood maltreatment included physical 
and sexual abuse, as well as neglect, harsh punishment, and poor mother-child interactions. With 
the severe forms of childhood maltreatment, social service departments have the authority to 
intervene in the family and remove children from this abusive environment. But this is not the 
case with these less severe forms of maltreatment. Consider a parent who smacks or ignores their 
child in public. The parent may be socially sanctioned, but it is unlikely that any legal action 
would be taken against the family. Or, less judgmentally, consider an impoverished, single 
parent who must work more than one job and spend hours away from home. In this case, neglect 
might be predictable even though it is entirely unintentional—a consequence of the parent’s 
socioeconomic status. What of the parents who fully admit that they often smack their current 
children with something and intend to continue this practice with their subsequent children? Or 
what of the parents who admit that their socioeconomic situation unintentionally leads to the 
neglect of their current children and will likely lead to the neglect of their subsequent children? 
Notice that these particular ethical questions regarding screening for an interactive 
predisposition are not raised by screening for a genetic predisposition.9 If there were a true 
genetic predisposition for ASPD or violence regardless of childhood maltreatment status, then a 
set of prospective parents whose child is likely to experience maltreatment and a set of 
prospective parents whose child is unlikely to experience maltreatment should both reach the 
                                                 
9 Of course, this does not imply that testing for genetic predispositions is at all easy. Judy Garber (1999), for 
instance, warns of the complex variety of considerations that must be made in testing for hereditary breast/ovarian 
cancer. My concern here is just to display how these variety of considerations become even more complex when a 
prediction must also be made about the environment.  
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same conclusion. If these two sets of parents both go to a genetic counselor in order to avoid, 
insofar as it is possible, having a child with behavioral problems, then a genetic counselor should 
make the same recommendation to both sets of parents: select against the low-MAOA embryo or 
fetus in order to lower the risk of having a child who develops ASPD. But with the interactive 
predisposition, the environmental conditions expected to be experienced during development 
must be figured into the decision.  
Caught by the trappings of the myth of pre-environmental prediction and assuming that 
the Caspi-Moffitt study displays a genetic predisposition to ASPD or violence, these different 
ethical questions are overlooked. It is only when we realize that the researchers found an instance 
of an interactive predisposition that we can appreciate the unique problems raised by their 
results. This is crucial information for the genetic counselor and the prospective parents who 
have visited their genetic counselor in order to reduce the chance of their child having ASPD. If 
parents can predict the presence or absence of childhood maltreatment, then this must be figured 
into the decision between selecting against the low- or the high-MAOA embryo or fetus. If the 
parents do not intend to maltreat the child and do not foresee that maltreatment will be a 
problem, then the genetic counselor would suggest selecting against the high-MAOA embryo or 
fetus. If the parents do intend to maltreat the child in spite of efforts to convince them otherwise, 
or if conditions are such that their child is likely to experience maltreatment in some form, then 
the genetic counselor would suggest selecting against the low-MAOA embryo or fetus.           
 
3.3. Newborn Screening and the Interventionist’s Dilemma 
The mandatory screening of newborns for genetic disorders raises interesting ethical questions 
(Newborn Screening Taskforce 2000; Pass et al. 2000). What is the purpose of such tests? For 
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whose benefit are the tests undertaken? What requirements in terms of predictive accuracy and 
treatment options must be met before a test is required? As of 2007, there are a handful of 
genetic tests mandated in the United States, with a great deal of variation between states (Green, 
Dolan, and Murray 2006; Therrell 2001). There are, however, increasing efforts to expand this 
pool (Hampton 2004; Howell 2006), along with pleas for caution (Botkin et al. 2006; Kerruish 
and Robertson 2005).  
 Could the results of the Caspi-Moffitt study be implemented in a policy of mandatory 
newborn screening program? The prospect is not as far-fetched as it might sound. The criteria for 
assessing a potential screening program proposed by Wilson and Jungner (1968) for the World 
Health Organization four decades ago remain the gold standard. Regarding knowledge of the 
disease, the condition must be an important health problem; there should be an identifiable latent 
or early symptomatic stage; and the natural history of the disease should be adequately 
understood. Regarding knowledge of the test, there should be a suitable test; the test should be 
acceptable to the population; and case finding should be an on-going process (i.e., the test should 
be made available on a continuing basis, and not just as a one-time search for cases). Regarding 
treatment for the disease, there should be an acceptable treatment for patients; facilities for 
treatment and diagnosis should be available; and there should be an agreed upon policy 
concerning who to treat as patients. Finally, regarding cost considerations, the costs of case 
finding should be economically balanced in relation to expenditures on medical care as a whole 
(Wilson and Jungner 1968).10   
 We can evaluate the possibility of a screening program based on the results of the Caspi-
Moffitt study by assessing how well the case of ASPD meets the Wilson-Jungner criteria. 
                                                 
10 It is worth noting that many of the 29 conditions recommended for testing by the Newborn Screening Task Force 
(2000) do not meet these criteria.  
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Regarding knowledge of the disease, ASPD certainly qualifies as an important health problem, 
both to the individual with ASPD and to the society in which the individual with ASPD lives. 
Violent crime is often characterized as a public health problem (Mercy, Rosenberg, Powell, 
Broome, and Roper 1999; Moore 1999). In turn, ASPD through its association with violent crime 
has also been characterized as a threat to public health (Fishbein 2000b; Potter and Mercy 1997). 
There is also a recognizable latent or early symptomatic stage for ASPD, namely childhood 
conduct disorder (Frick 1998; Reid, Patterson, and Snyder 2002). Now, admittedly, the full 
causal-mechanical explanation of the development of ASPD remains a mystery; its natural 
history is not completely understood. However, there is some debate about what the criterion of 
being “adequately understood” actually requires. Must the full causal mechanisms of the disease 
be understood? Or do we only need to know what causal variables are implicated in the 
development of the disorder? For a complex behavioral trait like ASPD, it is doubtful that the 
full causal-mechanical explanation will ever be elucidated; however, few diseases for which 
there already are screening programs meet this level of adequate understanding (Howell 2004). 
So there is reason to believe that even partial understanding of the causal story will satisfy this 
criterion.  
 Regarding knowledge of the test, the fact that Neuromark is already seeking FDA 
approval for such a genetic test obviously makes this a very real possibility. What it means for 
the test to be “acceptable to the population” is another debatable criterion. Screening for ASPD 
would clearly be a controversial step for any state to take, and it is very unlikely that any 
consensus position would form. However, a large portion of the population still may very well 
find such a measure acceptable in light of the potential decrease in violent crime that might 
result.  
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 Regarding treatment for the disease, this remains the most elusive achievement for 
researchers studying ASPD. An effective treatment for ASPD still does not exist in 2007, and 
without such an intervention, it is clear that this Wilson-Jungner criterion would not be met. 
Nevertheless, it seems prudent to consider the possibility of such a treatment. The most 
commonly mentioned possibility for treatment involves some form of pharmacological 
intervention, presumably altering an individual’s MAOA activity by, say, increasing MAOA 
activity for an individual with the low-MAOA genetic variant (call it an “MAOA boost”). 
Indeed, Caspi and Moffitt themselves conclude their empirical study with the line, “Both 
attributable risk and predictive sensitivity indicate that these findings could inform the 
development of future pharmacological treatments.” (Caspi et al. 2002, 853)  
 Finally, regarding cost considerations, it is worth reminding ourselves that 85% of the 
individuals from the low/severe sub-group in the Caspi-Moffitt study engaged in some form of 
antisocial behavior. And this sub-group, although amounting to only 12% of the study 
population, accounted for 44% of the study population’s convictions for violent crimes. 
Weighing the costs of identifying those at risk of developing ASPD against the costs of care for 
those who do develop ASPD is not a simple calculus. If, as Wilson and Jungner suggest, the 
costs are kept to purely medical concerns, then it is unclear that the balance would tip in favor of 
implementing such a screening program. However, if the costs of care also include such 
considerations as finding and then either treating or prosecuting/incarcerating those individuals 
with ASPD who engage in violent crimes, as well as the costs of care for those individuals who 
suffer from these violent crimes, then it is clear that a screening program would economically 
pay for itself with even a minimal decrease in violent crimes. 
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 The possibility of a screening program based on the results of the Caspi-Moffitt study has 
not escaped the notice of commentators. Ravinesh Kumar, for instance, suggests that “although 
likely to be highly controversial, we may decide to identify ‘at-risk’ individuals prone to 
developing antisocial tendencies by screening for the MAOA functional polymorphism and 
recognizing those who harbour the ‘low-activity’ variant” (Kumar 2003, 183). Paul Appelbaum, 
discussing the Caspi-Moffitt study, warns that “the pressure to screen is likely to increase if 
intervention can be shown to actually reduce crime. If effective treatment becomes available, the 
pressure to identify [at-risk] individuals through screening at birth may be irresistible” (quoted in 
Moran 2006). And Wasserman notes, “It would be tempting for the state to set a low threshold 
for pharmacological prevention for large categories of potentially vulnerable young men. For 
example ‘prescribing’ MAOA supplements for all young men screened as low MAOA, 
regardless of social class or family circumstances, would avoid blatant class bias, as well as 
intrusive and expensive inquiries into maltreatment [that] fell short of abuse and neglect” 
(Wasserman 2004, 28).   
 Again, Kumar, Applebaum, and Wasserman are not endorsing the implementation of a 
screening program based on the Caspi-Moffitt results. They are simply trying to draw attention 
to the ethical issues that would arise if a program were implemented to identify and intervene on 
the “at-risk” individuals deemed “genetically predisposed to violence.” But the lesson for 
preimplantation and fetal diagnosis is also applicable here: There is no way to determine who the 
individuals “at risk” for ASPD are before the environmental conditions are experienced (or at 
least reliably predicted). The genotype alone does not establish the relative risk of developing 
ASPD.  
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 But again, as with preimplantation and fetal diagnosis, recognizing the switch from a 
genetic predisposition to an interactive predisposition does not eliminate the ethical questions; 
instead, it raises a new dilemma unique to interactive predispositions—what I will call the 
interventionist’s dilemma. Briefly, the idea is the following: Early environmental stressors such 
as childhood maltreatment contribute to the development of CD and then ASPD, and so there is a 
premium on early intervention to combat the effects of these stressors; however, interventions 
that generalize and treat all individuals with low-MAOA (say, by pharmacologically increasing 
MAOA activity with the MAOA boost) would decrease the risk of developing ASPD for some 
individuals while simultaneously increasing the risk of developing ASPD for others. The 
developmental story is critical.11    
 Genes and the environment both contribute to the development of ASPD (Farrington 
1997; Rutter 1997). Cases of G×E reveal an interdependent causal relationship between the 
genetic variable and the environmental variable during the process of individual development 
(Tabery 2007, In Press). For ASPD, this developmental story starts early, manifesting itself first 
as CD and transitioning to ASPD once the individual turns 18. This developmental story is 
affirmed by the Caspi-Moffitt study. During childhood, an individual learns the process of moral 
deliberation from those who care for him or her. This process of learning occurs at multiple 
levels: social, organismal, brain-system, cellular, and molecular. In emotionally charged 
situations, neurotransmitters are released throughout the brain and controlled by the limbic 
system. MAOA, a neuroenzyme, is then responsible for breaking down those neurotransmitters 
                                                 
11 There is, of course, another option: use the genetic information as a guide to identify who is most in need of 
intervention on the environmental variable (i.e., prevention of exposure to childhood maltreatment). This chapter is 
devoted to the possibilities raised by the commentators on the ASPD study, and since none of the commentators 
have raised this possibility for this case, I will let it pass here too. However, environmental intervention is the main 
issue that I deal with in the next chapter (in the context of genetic tests for children), where I will argue that 
environmental interventions are rarely costless. Even in this case of ASPD, one can see how intervening on this 
environmental variable would lead to intrusions on family privacy and infringements on parental autonomy. But 
more on this later.         
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once the threat has passed. If caregivers maltreat the child through either neglect or abuse, these 
charged situations can become commonplace; and, without a sufficient supply of MAOA, 
heightened emotional response can persist for some time, ultimately having an impact on how 
the child learns to deal with conflict and resolution. Not surprisingly then, a premium is placed 
on early intervention in discussions of ASPD treatment—focusing on children and adolescents 
(McCord and Tremblay 1992). The rationale is that, once the environmental stressors are 
experienced and the disorder has developed, there is little hope of effective treatment in adults, 
who generally do not respond well to standard psychotherapy and suffer a high rate of recidivism 
for crime (Hemphill, Templeman, Wong, and Hare 1998). So the promise of a pharmacological 
intervention that could be implemented early in this developmental process is naturally 
appealing. The thought is that increasing MAOA activity for the low-MAOA individuals with an 
MAOA boost, thereby making them high-MAOA individuals, could act to buffer them against 
the environmental stressors that cause ASPD. After the environmental stressors have already 
been experienced, then the damage may be irrevocably done, thereby rendering the MAOA boost 
ineffective. If, however, the MAOA boost comes early—say, starting at birth—then the 
individuals may have the neurochemical resources to withstand the stress even at its earliest 
onset.     
 But notice that the warrant for this early intervention program requires ignoring the 
presence or absence of childhood maltreatment and treating all low-MAOA individuals at birth 
as if they are the at-risk population. For those low-MAOA individuals who experience childhood 
maltreatment, the potential advantage of early intervention is clear. In the Caspi-Moffitt study, 
individuals with low-MAOA activity were much more likely to develop ASPD in the presence of 
moderate and severe childhood maltreatment than were high-MAOA individuals. The 
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implication seems to be that an early intervention program that provided a pharmacological 
MAOA boost to those individuals might have prevented many of them from going on to engage 
in antisocial behavior. But if the early intervention program starts at birth and ignores the 
presence or absence of childhood maltreatment, then this means that the individuals in the 
environment without childhood maltreatment will also receive the pharmacological MAOA 
boost. Recalling Figure 3.1, note what will happen to the rate of ASPD for that population: It will 
increase. That is, the pharmacological intervention boosting all low-MAOA individuals to high-
MAOA individuals will decrease the risk of developing ASPD for those individuals who 
experienced maltreatment while simultaneously increasing the risk of developing ASPD for 
those individuals who do not experience maltreatment. 
 The two horns between which the interventionist is caught should now be clear. On the 
one hand, the fact that ASPD is a developmental disorder with early onset militates for an early 
intervention program in order to provide a treatment before the environmental stressors take their 
toll. On the other hand, embracing this early intervention strategy necessitates treating all low-
MAOA individuals from birth before knowledge of childhood maltreatment is known, thereby 
decreasing the risk of some while increasing the risk of others. The way past the second horn is 
to wait and see who does and does not experience childhood maltreatment, and to intervene 
pharmacologically only once the presence of the environmental stressor can be confirmed. 
However, waiting pushes the interventionist back on the first horn of the dilemma: Wait until 
childhood maltreatment can be confirmed, and the damage may already be done.        
 Now, one response to the interventionist’s dilemma might be a kind of utilitarian 
comparison of sub-groups. The thought here would be to first note how many 
MAOA/maltreatment sub-groups there are in the Caspi-Moffitt study—6: low/none, 
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low/probable, low/severe, high/none, high/probable, and high/severe. Then, turning to Figure 
3.1, a comparison is made at each environment (none, probable, and severe) of whether the 
switch from low- to high-MAOA activity leads to an increase or a decrease in risk of ASPD. If it 
leads to a decrease, then that is a point in favor of the early intervention program; if it leads to an 
increase, then that is a point against the early intervention program. On this calculus, the 
interventionist pushes through the dilemma and decides to intervene. In two of the environments 
(probable and severe), the switch from low- to high-MAOA activity leads to a decrease in risk. 
In only one of the environments (none), the switch from low- to high-MAOA activity leads to an 
increase in risk. Two beats one. But this solution belies important information about the 
constitution of these sub-groups. The switch from low- to high-MAOA activity does decrease the 
risk of developing ASPD in two of the environments measured. But only 1/3 of the population 
from the Caspi-Moffitt study fell into these two environments, whereas 2/3 of the population from 
the Caspi-Moffitt study fell into the environment without childhood maltreatment. This should 
not be surprising; most parents do not maltreat their children. Ultimately, then, implementing the 
early intervention program would lead to a decrease in risk for 1/3 of the population and an 
increase in risk for 2/3 of the population. Admittedly, the decrease in risk is substantial, while the 
increase in risk is slight. But even a slight increase in risk for a full 2/3 of the population should 
suggest taking pause before any early intervention program is implemented. If such a public 
policy was implemented, then some form of consensus committee would need to be formed in 
order to work through the implications of this dilemma.  
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3.4. Conclusion 
This chapter explored several of the ethical questions that arise when efforts are made to screen 
for an interactive predisposition to ASPD. Commentators reflecting on the Caspi-Moffitt study 
have treated the case as if the ethical questions arise from the problems posed by screening for a 
“genetic predisposition to ASPD or violence” in order to identify the “at-risk” population with 
the low-MAOA variant. Thus, the analyses have been framed around the standard questions 
raised by screening for genetic predispositions.  
The lesson of chapter 2 was that Caspi and Moffitt identified an instance of an interactive 
predisposition, not a genetic predisposition. This chapter has been devoted to tracking a few of 
the ethical implications of that conceptual shift. The ethical questions surrounding genetic 
screening must be reframed in cases of interactive predispositions. With regard to 
preimplantation diagnosis or fetal screening, the thought that screening against low-MAOA 
individuals will lead to a decreased risk in developing ASPD suffers from the myth of pre-
environmental prediction. There is simply no way to assess whether low- or high-MAOA 
individuals are more or less at risk of developing ASPD until the environmental conditions of 
development are either experienced or reliably predicted. With regard to newborn screening, the 
thought that identifying and pharmacologically treating low-MAOA individuals from birth, as 
part of an early intervention program aimed towards preventing the development of ASPD, must 
face the interventionist’s dilemma. A successful treatment program seems to require an early 
intervention, perhaps even beginning at birth; however, an MAOA boost to low-MAOA 
individuals from birth would both decrease the risk of developing ASPD for some individuals 
while simultaneously increasing the risk of developing ASPD for many more individuals.                 
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4. TESTING CHILDREN FOR INTERACTIVE PREDISPOSITIONS 
 
Abstract. Genetically testing a child for susceptibility to a disease or disorder involves many 
potential benefits and burdens. Typically, the ethical analysis of such cases involves, in part, a 
cost-benefit analysis to determine whether the advantages outweigh the disadvantages of 
obtaining the genetic information about a child. Commentators thus far have focused exclusively 
on cases of genetic determinism (think Huntington’s disease) and genetic predisposition (think 
hereditary breast/ovarian cancer). In such cases there is a clear at-risk genotype, and the analysis 
of testing for the genotype proceeds by considering potential burdens such as negative 
psychosocial impacts alongside potential benefits such as preventive intervention. In cases of 
interactive predisposition, however, there are no at-risk genotypes; there are at-risk gene-
environment combinations. The purpose of this chapter is to explore how the cost-benefit 
analysis involved in decisions concerning genetically testing children must be adapted in light of 
this switch from risky genotypes to risky gene-environment combinations. Cases of interactive 
predispositions for a variety of diseases and disorders are becoming commonplace, making such 
an adaptation a necessary anticipation of the ethical considerations that will follow from 
available tests for these cases.    
 
4.1. Introduction 
So far in the thesis I have focused solely on the MAOA study by Caspi and Moffitt (2002), as 
well as on the ethical questions raised by commentators who have considered that study. The 
goal of chapter 2 was to show that the Caspi-Moffitt MAOA study identified an interactive 
predisposition, not a genetic predisposition. And the goal of chapter 3 was to explore how that 
switch reconfigured the ethical questions raised by commentators concerning embryonic, fetal, 
and newborn screening for MAOA status.  
 In this chapter I open up the discussion to consider cases of interactive predispositions 
beyond the MAOA study, as well as ethical questions beyond those raised by the commentators 
on the MAOA study. There is good reason to expand the discussion in this manner, since 
discoveries of interactive predispositions for a variety of complex traits are becoming 
commonplace. Consider three recent cases. In 2005, Sabine Hoffjan and her colleagues 
published a study on the relationship between functional polymorphisms at several loci, exposure 
to daycare, and the subsequent development of immunologic responses predictive of asthma 
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(Hoffjan et al. 2005). For instance, the NOS3_298 polymorphism (Glu → Asp) results in three 
possible genetic variants: Glu/Glu, Glu/Asp, and Asp/Asp. Children with these genetic variants 
were then monitored by Hoffjan and her colleagues in an array of environments—namely, 
exposure to or lack of exposure to daycare in the first year of life. The phenotypic trait under 
investigation, then, was the change in interleukin-13 (IL-13) response levels over the course of 
that year. IL-13, one of the many Th2 cytokines (or messenger cells) in the immunological 
system, has been identified as a necessary and sufficient cause for allergic asthma; increased 
levels of IL-13 activity lead to the subsequent development of allergic asthma, while decreased 
levels apparently ensure its absence (Wills-Karp and Chiaramonte 2003). With the data on each 
genetic variant’s IL-13 response level in each environment, Hoffjan and her colleagues then 
constructed a reaction norm graph for the phenotypic curves (Figure 4.1). They concluded, 
“[o]verall, the children with the Asp/Asp genotype who did not attend day care had the highest 
levels of and greatest increases in Th2 cytokine responses, whereas the children with the 
Asp/Asp genotype who attended day care had the lowest levels of and smallest increases in Th2 
cytokine responses”—the hallmark of an interactive predisposition (Hoffjan et al. 2005, 698). 
Also note the fact that the effect of daycare exposure led to the drastic decrease in IL-13 
response for the individuals with the Asp/Asp genotype, while simultaneously leading to a slight 
increase in IL-13 response for the individuals with the Glu/Glu and the Glu/Asp genotype.  
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 Figure 4.1. Reaction norm graph for NOS3_298 polymorphism, exposure to day care, and IL-13 
response (From Hoffjan et al. 2005, Figure 1A). 
 
 In another study, Karl-Erik Wahlberg and his colleagues investigated the relationship 
between adoptees’ genotypes, exposure to communication deviance from the adoptive parents, 
and the subsequent development of cognitive processes symptomatic of schizophrenia (Wahlberg 
et al. 1997). The adoptees were classified as carrying either a high-risk genotype or a low-risk 
genotype based upon whether or not their biological mothers were schizophrenic. The high- and 
low-risk adoptees were then monitored for how they responded to patterns of communication 
deviance in their adoptive parents. Communication deviance is a pattern of communication on 
the part of a speaker that systematically befuddles and distracts a listener, who is attempting to 
join in a shared focus of attention with the speaker; communication deviance is essentially 
language that is ambiguous and difficult for a listener to follow, although it would not by itself 
be taken as evidence of a psychiatric disorder in the speaker (Singer and Wynne 1966). The 
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phenotypic trait that Wahlberg and his colleagues studied in the adoptees, then, was thought 
disorder (generally taken to be either an indicator of susceptibility to developing schizophrenia 
or even as a part of the extended schizophrenic spectrum), measured by means of Rorschach 
tests. With the data on evidence of thought disorder for individuals with each genotype in each 
environment, Wahlberg and his colleagues then constructed a reaction norm graph for each of 
the phenotypic curves (Figure 4.2), revealing the change in rank between the genotypes. Again, 
note the fact that exposure to increasing levels of communication deviance drastically increased 
the proportion of high-risk adoptees developing thought disorder, while simultaneously 
decreasing the proportion of low-risk adoptees developing thought disorder.   
 
 
Figure 4.2. Reaction norm graph for high- vs. low- genotypic risk in adoptees, exposure to 
communication deviance in adoptive parents, and subsequent development of thought disorder 
(From Wahlberg et al. 1997, Figure 1). 
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 One more example. A year after Caspi and Moffitt published their MAOA study, they 
published another study examining the relationship between a functional polymorphism in the 
promoter region of the serotonin transporter gene, exposure to stressful life events, and the 
subsequent development of depression (Caspi et al. 2003). Serotonin transporters are proteins on 
the synaptic membranes of neurons involved in the reuptake of neurotransmitters after they have 
been released in the synapse. The number of these proteins produced at a synapse is regulated by 
the promoter region of the serotonin transporter gene, which is itself based on the length of that 
promoter region. Individuals receive one copy from each of their parents, which can be either 
short (s) or long (l); thus, individuals can be classified as either s/s, s/l, or l/l. Individuals with the 
various polymorphisms were then monitored for how they responded to stressful life events, such 
as the death of a loved one or the loss of a job. The phenotypic trait that Caspi, Moffitt and their 
colleagues examined in this study was major depression. With the data on genotype, exposure to 
stressful life events, and the subsequent development of depression, Caspi, Mofitt, and their 
colleagues constructed reaction norm graphs for each of the phenotypic curves (Figure 4.3a), 
revealing the change in rank between the genotypes. This study has since been replicated by T.C. 
Eley and colleagues in an adolescent population (Eley et al. 2004), with results consistent with 
the change in rank (Figure 4.3b).12 Interestingly, the researchers conducting the replication in 
adolescents only found the associated risk of depression in female participants. (Note also that in 
Figure 4.3b it is now the environmental variable plotted across the array of genotypes; thus, this 
is actually a phenotypic curve for the environments, not the genotypes. Nevertheless, the change 
in rank is still apparent. Individuals with the s/s genotype are at the lowest risk of depression in 
the low-risk environment and at the highest risk of depression in the high-risk environment; and 
                                                 
12 Replications of the interaction effect have also been reported by Grabe et al. (2005), Kaufman et al. (2004), 
Kaufman et al. (2006), Kendler et al. (2005), and Wilhelm et al. (2006). Two failures to replicate have been reported 
as well by Gillespie et al. (2005) and Surtees et al. (2005).   
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this risk increase is in the opposite direction for individuals with the l/l genotype, who experience 
the increased risk of depressive symptoms as they move from the high-risk environment to the 
low-risk environment.) 
 
(a) (b) 
Figure 4.3. Reaction norm graphs for the serotonin transporter gene, exposure to stressful life 
events, and the subsequent development of depression or depressive symptoms. (a) In an adult 
population of both males and females (From Caspi et al. 2002, Figure 1B). (b) In an adolescent 
population of females (From Eley et al. 2004, Figure 1).  
   
 Like the Caspi-Moffitt study on ASPD, the asthma study, the schizophrenia study, and 
the depression study all are cases of G×E resulting in a change in rank; all are cases of an 
interactive predisposition. But in spite of this commonality, the ASPD study has certainly stolen 
the spotlight.13 Perhaps this should not be surprising. The very prospect of a ‘gene for violence’ 
or even a ‘genetic predisposition to violence’ raises a host of obvious ethical questions, as was 
                                                 
13 As evidence of this overshadowing by the ASPD study, a September 2007 citation survey of these articles found 
Caspi et al. (2002) cited 503 times, while Hoffjan et al. (2005) was only cited 30 times, and Wahlberg et al. (1997) 
was only cited 74 times (www.isiwebofknowledge.com). Caspi et al. (2003) is an exception to this rule; it was cited 
800 times. However, it has not received the same attention from bioethical and legal scholars as the ASPD study.   
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documented in the last chapter. But if we focus our attention on preventing the development of 
ASPD, then that case is actually a fairly easy one to solve: just don’t maltreat the children! 
While there may be some debate over the appropriateness of physical punishment, most 
reasonable adults will agree that the sexual assault, physical abuse, and neglect of children are 
reprehensible. If parents or a society want to prevent the development of ASPD, simply combat 
the environmental stressor…a stressor that most agree is repugnant in the first place. 
 Ironically, as we shift our attention from the highly-publicized ASPD study to the less-
scrutinized asthma, schizophrenia, and depression studies, the ethical questions become more 
difficult to answer precisely because the environmental stressors in these cases lack the 
reprehensibility identified in the ASPD study. The decision to send a child to daycare is a 
complex parental decision; available finances, available time, and philosophies of life and 
parenting all come into consideration. Are parents parenting poorly if they send their child to 
daycare? Are they parenting poorly if they do not? Should genetic information about a child 
figure into this parental decision? Communication deviance, though a headache for the listener, 
is not a crime; it is not even evidence of a psychiatric disorder in the speaker. For some adoptees, 
communication deviance in their adopted parents apparently lowers the risk of thought disorder; 
while, for other adoptees, communication deviance in their adopted parents apparently increases 
the risk of thought disorder. Are adoptive parents harming their adopted child if they do engage 
in communication deviance with a high-risk adoptees? Are adoptive parents harming their 
adopted child if they do not engage in communication deviance with a low-risk adoptees? Should 
genetic information about adoptees be gathered for the sake of matching them with the 
appropriate adoptive parents based upon the adoptive parents’ communication styles? Stressful 
life events are often out of anyone’s control. Who do we blame for the death of a loved one or 
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the loss of a job? Should genetic information be gathered from children in order to determine 
who among them are most susceptible to the trauma from these stressful but unpredictable life 
events?  
Neuromark, the same company seeking FDA approval for a genetic test of MAOA status, 
is also seeking FDA approval for a genetic test of the serotonin transporter gene. Importantly, 
when CEO Kim Bechtold was asked about the use of such a test, she offered up the possibility of 
parents testing their children as a potential venue.14 Thus, as was the case with the discussion of 
MAOA in the previous chapter, the discussion here is more than abstract speculation; a test for 
the serotonin transporter gene may very well be available to parents in the near future.  
 In this chapter I consider how cases of interactive predispositions should figure into the 
ongoing debate over genetically testing children. Few argue that genetically testing children 
should never be done, or that it should always be permitted. Instead, the ethical analysis of such 
tests generally follows a cost-benefit analysis of undertaking the test and acquiring the child’s 
genetic information. The ethical debate revolves around what these costs and benefits are, how 
costly and beneficial they actually are, and who is in the best position to weigh the two. So far, 
the ethical debate has focused exclusively on cases of genetic determinism (think Huntington’s 
disease) and genetic predisposition (think hereditary breast/ovarian cancer). In such cases, there 
is a clear at-risk genotype, and the cost-benefit analysis proceeds by considering the costs and 
benefits of identifying the risk status associated with an individual’s genotype, such as the threat 
of genetic discrimination or the promise of medical intervention. In cases of interactive 
predisposition, however, there are no at-risk genotypes. There are only at-risk gene-environment 
                                                 
14 I undertook a phone interview with Bechthold on Friday, June 9, 2006. Information obtained in that conversation 
is not to be further cited or discussed with other parties. 
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combinations. The goal of this chapter is to explore how this switch reconfigures the cost-benefit 
analysis involved in deciding whether or not to genetically test a child.       
 
4.2. Testing Children for Genetic Predispositions:  
Weighing the Burdens and Benefits  
A 1993 survey of 49 geneticists and 260 pediatricians by the UK Working Party of the Clinical 
Genetics Society found that the majority of these healthcare providers would, upon parental 
request, provide presymptomatic genetic testing for a 5-year old child for a host of disorders 
including Huntington’s disease (Working Party 1994). This information quickly elicited a series 
of publications from physicians, moral philosophers, and legal scholars, who questioned the 
ethical foundation upon which such tests were warranted (Andrews et al. 1994; Hoffmann and 
Wulfsberg 1995; Wertz, Fanos, and Reilly 1994). There were differences in foci for these 
commentators; however, they reached something of a consensus regarding the appropriateness of 
genetically testing children for diseases, such as cystic fibrosis, Huntington’s disease, or 
phenylketonuria (PKU).  
 The essence of a genetic predisposition is that there is a clear at-risk genotype. The 
purpose of a genetic test, then, is to determine whether an individual (in this case, a child) bears 
that risky genotype. The various teams of authors responding to the UK Working Party’s 
findings noted that there are a number of benefits and burdens that potentially follow from 
learning that a child has a risky genotype. On the beneficial side, obtaining this genetic 
information about a child ideally suggests a timely course of medical treatment that can prevent 
the development of a disease (see also Kodish 1999). For instance, a positive genetic test for 
PKU in a newborn suggests a course of medical treatment involving a dietary modification that 
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eliminates phenylalanine, since children with PKU cannot metabolize this amino acid. 
Eliminating phenylalanine from the diet thereby prevents the mental retardation and seizures that 
follow from the buildup of this amino acid. Or, a positive genetic test for familial adenomatous 
polyposis (FAP) in a child suggests a course of medical monitoring and intervention involving 
regular colonoscopies and ultimately a colectomy, since an adolescent or young adult with FAP 
will likely develop hundreds of pre-cancerous polyps on their colon without this surgery.  
 The authors responding to the UK Working Party’s findings, however, were much more 
concerned with the burdens that might come with obtaining genetic information from children. A 
positive genetic test for, say, mutations in either the BRCA1 or BRCA2 genes (implicated in 
hereditary breast/ovarian cancer) might have social costs. The children could be stigmatized long 
before they are ever symptomatic. Or, the children could experience discrimination from 
insurance companies or employers, which translates into a financial cost as well. A positive 
genetic test might also have familial costs. Parents might treat their child as if their future is 
limited, shift familial resources away from this child, or become overprotective of the child 
(vulnerable child syndrome) (see also Farrell et al. 1991). There may also be severe stress placed 
on the parent-child bond. A parent or the parents may feel personally responsible for the positive 
result. Or, a positive result in one child and a negative result in a sibling may lead to feelings of 
‘survivor’s guilt’ in the low-risk sibling, thereby straining the sibling bond (see also Wexler 
1985; Biesecker et al. 1993). A positive genetic test might also have psychological costs (see 
also Marteau and Croyle 1998). The child may experience the negative effects of altered family 
dynamics, feel unworthy, experience a loss of self-esteem, become depressed, or even come to 
question his/her own sense of self (see also Bloch and Hayden 1990; Koocher 1986). In short, 
the child, the members of the family, and the members of the larger social network may begin 
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treating the genetic result as an inevitability, despite the probabilistic nature of the information 
(see also Dreyfuss and Nelkin 1992). There is also the cost of lost autonomy. In genetically 
testing a child, parents and the health care provider(s) take away the child’s ability to make the 
decision about whether or not to be tested in the future, perhaps violating the child’s right to an 
‘open future’ (see also Bloch and Hayden 1990; Davis 1997; Feinberg 1980). 
 With these potential benefits and burdens under consideration, Andrews et al. (1994), 
Hoffman and Wulfsberg (1995), and Wertz, Fanos, and Reilly (1994) encouraged undertaking a 
cost-benefit analysis of these factors. As Hoffman and Wulfsberg summarize, “The decision by a 
physician to offer or perform a presymptomatic genetic test and by a parent to have their child 
tested will require weighing the possible benefits of the test with its impact on the child’s quality 
of life” (ibid, 334). With the best interests of the child as the guide, the authors made the 
following recommendations based on the availability of timely medical treatments: 
• In the case of a disease with childhood-onset and with a known, medical, preventive 
treatment/intervention (such as PKU), physicians and parents should undertake genetic 
testing.  
• In the case of a disease with adult-onset and with no known, medical, preventive 
treatment/intervention (such as Huntington’s disease), physicians and parents should not 
undertake genetic testing.  
• Children should be included in the decision-making process to the extent that they are 
developmentally capable of engaging in the process of assent.15  
So what if parents want to undertake genetic testing on their child for an adult-onset 
disease, or for a disease with no known, medical, preventive treatments/interventions? Are 
                                                 
15 The authors also discuss genetic testing for carrier status and for the benefit of another family member. These 
other situations, however, are less relevant to the cases of interactive predispositions that I will be discussing, so I 
will focus my attention on the recommendations above. 
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physicians obligated to comply with the parents’ request? Legally, the answer is, no; physicians 
are not obligated to provide therapeutic/diagnostic tests such as genetic tests (Clayton 1995). 
However, we may proceed to ask whether they are morally obligated to comply. For the authors 
responding to the UK Working Party’s findings, the answer is again, no. For instance, Wertz, 
Fanos, and Reilly advise, “Sometimes the physician must reject a request, whether from a parent 
or a minor, if in the physician’s judgment it serves no useful purpose and may lead to harm. For 
example, a parental request to test a 7-year-old for predisposition to familial Alzheimer’s disease 
provides no medical benefit to the child and may lead to stigmatization. Decisions that challenge 
parental autonomy may be necessary to prevent harm and to preserve a minor’s future autonomy, 
which should be the paramount considerations” (ibid, 878). Denying such tests, they explain, is 
justified medical paternalism. And Hoffman and Wulfsberg concur: “Although parents generally 
know their child best and care most about the child’s welfare, we believe that physicians and 
health care providers have an obligation to provide them with sufficient information to make a 
true informed decision about the benefits and risks associated with testing for a genetic 
predisposition” (ibid, 336).  
 These authors apply the same reasoning to cases of adoption. Testing should be 
undertaken with the best interests of the child in mind. Of course, a negative test result for a 
disease may make the child more likely to be adopted, but a positive test result will 
simultaneously make the child less likely to be adopted. Wertz, Fanos, and Reilly, for instance, 
warn, “Testing for untreatable adult-onset disorders prior to adoption makes the child into a 
commodity undergoing quality control” (ibid, 879)  
 The analysis provided by Andrews et al. (1994), Hoffman and Wulfsberg (1995), and 
Wertz, Fanos, and Reilly (1994) has been largely adopted, nationally and internationally, by 
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professional organizations considering the genetic testing of children. Ethics committees from 
the American Academy of Pediatrics (2001), the American Medical Association, AMA (1996), 
the American Society of Human Genetics and the American College of Medical Genetics, 
ASHG/ACMG (2000), the Canadian Pediatric Society, CPS (2003), and the World Health 
Organization, WHO (2003) have reaffirmed the potential burdens and benefits of testing children 
for genetic diseases as well as the subsequent cost-benefit analysis of those factors.16 The 
AMA’s statement is representative of this group. Noting the potential burdens and benefits of 
genetic testing in children, the AMA explains, “…there must be some potential benefit from the 
testing that can reasonably be viewed as outweighing the disadvantages of testing…” (AMA 
1996, E-2.138). The AMA then reaches the expected conclusions: test children for diseases with 
childhood-onset and which have known, medical, preventive treatments/interventions; do not test 
children for diseases with adult-onset and which have no known, medical, preventive 
treatments/interventions. The Association also warns, “If parents unreasonably request or refuse 
testing of their child, the physician should take steps to change or, if necessary, use legal means 
to override the parents’ choice.” (ibid)17   
 The medical associations also reached similar conclusions regarding the testing of 
adoptees. The joint recommendations from ASHG/ACMG, which dealt specifically with genetic 
testing in adoption, warned that identifying an at-risk genotype in adoptees may adversely affect 
the chances of adoption. Thus, they suggested keeping the best interests of the child in mind and 
only testing for childhood-onset diseases with a timely course of preventive intervention 
available. Interestingly, the ASHG/ACMG statement also recommended, “In the adoption 
                                                 
16 Though not official recommendations from professional organizations, Cline (1999) and Bove, Fry, and 
MacDonald (1997) also affirmed for nursing communities the analysis laid out by Andrews et al. (1994), Hoffman 
and Wulfsberg (1995), and Wertz, Fanos, and Reilly (1994).  
17 And, again, the AMA discusses testing for carrier status or for the benefit of another family member reaching 
conclusions similar to those mentioned above.  
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process newborns and children should not be tested for the purpose of detecting genetic 
variations of or predispositions to physical, mental, or behavioral traits within the normal range” 
(ASHG/ACMG 2000, 761).    
 More recently several authors, though not questioning the general cost-benefit analysis 
involved in the decision, do encourage a more complex appreciation for the burdens and benefits 
(Clayton 1997; Cohen 1998; Ross 2002). In general, they suggest moving beyond the standard 
cases of cystic fibrosis, Huntington’s disease, and PKU, in order to frame and specify the ethical 
analysis around the greater variety of tests available for diseases that do not have the same 
penetrance as these diseases. Moreover, they draw attention to the variety of benefits obtained 
from positive and negative test results that are overlooked by earlier authors. Cynthia Cohen 
(1998), for instance, argues that the purported social, familial, and psychological costs of genetic 
testing are either anecdotal or derive from research on testing for Huntington’s disease, making 
questionable the evidence of burdens associated with testing for genetic predispositions more 
generally. Cohen suggests that, rather than violating the child’s autonomy, testing may actually 
enhance it; obtaining the genetic information makes apparent certain risks or lack of risks, 
thereby allowing the child (and the parents) to have the knowledge necessary to make decisions 
about how to prepare for and ultimately live with (or without) a disease. Rather than following 
rigid recommendations that consider only the dichotomy between childhood and adult-onset, as 
well as the rigid dichotomy between a timely medical treatment/intervention or the lack thereof, 
Cohen suggests taking into account a complex of factors when considering a genetic test for a 
child, such as the remoteness of disease onset, the severity of the disease, the potential 
development of future medical technologies, the maturity of the child, the availability of genetic 
counseling, and the likelihood of occurrence alongside the rate of occurrence in the general 
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population. Ultimately, Cohen advises, the cost-benefit analysis results in a draw; therefore, the 
value-laden nature of the decision must be recognized, and parents should be given wide room to 
decide when and when not to test their children.  
Ellen Wright Clayton (1997) and Lainie Friedman Ross (2002) reach a similar 
conclusion, although their focus is less on reconsidering the benefits/burdens and more on 
reconsidering who is in the best position to identify and weigh those benefits/burdens when the 
analysis becomes increasingly complicated and value-laden. While Clayton and Ross agree that 
genetic testing should be avoided when the test presents clear and substantial harm to a child, 
they counter that parents are in the best position to weigh the factors when the risk is not so 
obvious and dire. In U.S. culture, Clayton notes, parents are given substantial leeway to decide 
what is in the best interests of their child; for instance, there is quite a bit of disagreement over 
the physical punishment of children, yet parents are permitted to engage in or refrain from 
physically punishing their children without outside interference. Clayton and Ross also both 
point out that parents, in making medical decisions about members of the family, must consider a 
variety of familial factors some of which involve the best interest of individuals in the family 
(such as a child) and some of which involve the best interest of the family as a unit, which 
ultimately affects the individuals in the family (see Ross 1998 more generally on this issue). 
Ross, for example, points out that results from a genetic test can shape decisions about where to 
buy a home based on its proximity to appropriate, disease-specific health care, or about what 
style of a home to buy based upon whether or not, say, stairs will present a problem for a child 
with a specific disease.   
I find the contributions from Clayton (1997), Cohen (1998), and Ross (2002) particularly 
applicable to cases of interactive predispositions, such as those mentioned in the introduction to 
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this chapter. Take, for instance, the cases of depression or schizophrenia. Psychiatric diseases 
and disorders do not fit easily onto the rigid dichotomy between childhood-onset and adult-onset 
diseases. There is quite a bit of variation in onset for these cases, as there is for a host of diseases 
and disorders. Moreover, the nature of interactive predispositions suggests that the diseases and 
disorders themselves involve complex interactions between genes and the environment which 
play out over time; a final diagnosis of schizophrenia may come in adulthood, but other traits 
symptomatic of the disease (such as thought disorder) may develop in childhood or adolescence. 
Or consider the case of asthma. A decision about daycare forces parents to consider a variety of 
familial factors, which include both the direct best interests of the child as well as indirect 
familial interests pertaining to finances, schedules, and parenting philosophies that ultimately 
affect the child anyway. In this situation, the rigid dichotomy between the existence or absence 
of a timely medical treatment/intervention breaks down. The treatment, in this case, is not 
pharmacological or surgical; it is educational/developmental—exposure to daycare. In turning, 
then, to potential tests for interactive predispositions, I will keep the recommendations of 
Clayton (1997), Cohen (1998), and Ross (2002) in focus as a guide for evaluating the complex 
medical, social, familial, and psychological factors involved in analyzing whether or not to 
undertake such tests.     
  
4.3. Testing Children for Interactive Predispositions:  
Reconsidering the Burdens and Benefits  
The essence of a genetic predisposition is that there is an at-risk genotype. The essence of an 
interactive predisposition is that there is an at-risk gene-environment combination. What are the 
implications of this switch from risky genotypes to risky gene-environment combinations in the 
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context of genetic tests for children? One of the lessons from Clayton (1997), Cohen (1998), and 
Ross (2002) is that genetic tests for children must be evaluated individually in order to tailor the 
cost-benefit analysis to the test at hand (as opposed to extrapolating from tests for Huntington’s 
disease or cystic fibrosis). This is good advice; however, it does not prevent us from making 
some general observations about testing children for interactive predispositions. Let me begin, 
then, by drawing attention to several general features of tests for interactive predispositions and 
then take this general analysis to specific cases, such as tests for the interactive predispositions 
mentioned in the introduction to this chapter—asthma, depression, and schizophrenia.  
 
4.3.1. Reconfiguring the Benefits and Burdens: General Considerations  
The risk status associated with an interactive predisposition requires knowledge of both the 
genetic variable and the environmental variable; the risk status may only be determined once the 
values of both these variables are known. The genetic test is designed to determine the value of 
the genetic variable; for example, a test for the NOS3_298 polymorphism would be designed to 
determine whether this genetic variable takes the value of Glu/Glu, Glu/Asp, or Asp/Asp for an 
individual. But the genetic test undertaken in the case of an interactive predisposition supplies 
only half of the information required for evaluating risk status. There must be something of an 
environmental test as well. That is, information must also be sought concerning the value of the 
environmental variable; for example, an evaluation of the risk associated with the interactive 
predisposition for asthma would involve information about whether or not the individual will be 
exposed to daycare. Incorporating this environmental test into the equation raises a series of 
questions alongside the usual questions raised about obtaining information about the genetic 
variable:  
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• Can information about the environmental variable be reliably obtained? That is, is the 
environmental variable under someone’s control, so that the value of this variable can be 
intentionally selected, or is there some degree of chance involved in what value the 
environmental variable may take?  
• If the environmental variable is under someone’s control, what does avoiding or attaining 
a particular environmental value entail? For instance, are there financial or scheduling 
commitments that must be made in order to ensure that the environmental variable takes a 
certain value for the child, or are there psychological or social costs of ensuring that the 
environmental variable does not take a certain value for the child?  
• What does obtaining this environmental information entail? That is, is it simply a matter 
of asking parents a yes/no question, or does it involve acquiring information in a more 
complicated or invasive manner?  
When the determination of an individual’s risk status requires information about both the 
genetic and the environmental variables, the cost-benefit analysis involved in deciding whether 
or not to test the individual, especially a child, is reconfigured. As discussed above, many of the 
costs associated with a positive result in a genetic test stem from embracing a genetic 
essentialism and treating the probabilistic genetic information as if it was a deterministic 
inevitability (Dreyfuss and Nelkin 1992). Perhaps this should not be surprising. Without a viable 
genetic engineering program, the value that the genetic variable takes for an individual is fixed. 
As of 2007, it is not currently possible to change an individual’s genotype from Asp/Asp to 
Glu/Glu at the site of the NOS3_298 polymorphism. Of course, various dietary, pharmacological, 
surgical, or environmental manipulations may be made to react to the products of a genetic 
variable, but the value itself is not manipulated.  
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With an interactive predisposition, however, there is a very real sense in which the value 
of the environmental variable may be manipulated. It is, in principle at least, possible to decide 
whether or not a child is exposed to day care. Of course, as mentioned above, one of the 
important questions to consider pertains to the costs of practically manipulating this variable. 
Nevertheless, the very possibility of it should not be overlooked or treated lightly. With cases of 
interactive predisposition, the genetic information alone does not confer risk status, and so costs 
such as stigmatization, discrimination, or loss of self-esteem should not (in principle) follow 
from information about genetic status alone. In this sense, then, the costs of obtaining the genetic 
information about a child in cases of interactive predisposition are reconfigured since that 
genetic information alone does not lend itself to the potential burdens in the same way as cases 
of genetic predisposition. 
That said, cases of interactive predisposition, since they incorporate a genetic and an 
environmental variable in the risk analysis, may actually lend themselves to even costlier 
burdens than cases of genetic predisposition. Consider the burdens associated with fatalistic 
attitudes. An individual with a risky genotype in a risky environment may feel as if s/he has been 
hit with a double-dose of bad luck; perhaps this will be perceived as an even greater inevitability 
than just a genetic predisposition even though the information is still probabilistic. Or, consider 
feelings of responsibility on the part of parents who learn of a positive test result for their child. 
In the case of a genetic predisposition, this can be combated with educational information about 
the unavoidable element of chance involved in genetics; parents should not feel responsible if a 
genetic roll of the dice fell unfavorably for their child. But with an interactive predisposition, the 
environmental variable is in play, and so there is the in-principle ability to manipulate that value. 
The practical costs of such manipulation, however, may be very high; for example, manipulating 
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the value of the environmental variable may have financial costs beyond those that the parents 
can afford. The appeal to genetics, described as a factor beyond parental control, made to reduce 
guilt associated with genetic contributions to their child’s condition may now reinforce guilt 
associated with environmental factors.  
 Another general feature to keep in mind in cases of interactive predisposition pertains to 
the extent to which parents will understand the nature of the risk status that incorporates both a 
genetic and an environmental variable. There are a number of empirical studies suggesting that 
clinicians and patients alike have difficulty understanding probabilistic information, that 
clinicians and patients have different interpretations of what is and is not risky, that clinicians 
and patients have different preferences for probability expressions, and that patients ultimately 
do not understand the probabilistic information given to them (Chase, Faden, Holtzman et al. 
1986; Gigerenzer 2002; Kessler and Levine 1987; Michie, Lester, Pinto, and Marteau 2005; 
Wertz and Fletcher 1987; Wertz, Sorenson, and Heeren 1986). Moreover, these studies involve 
cases with probabilities associated with only one variable—the genetic. So it is reasonable to 
assume that these problems of comprehension, appreciation, and deliberation will only be 
magnified in cases of interactive predisposition where both genetic and environmental variables, 
each probabilistic in nature, are involved. Fortunately, Celeste Condit and her colleagues at the 
University of Georgia have begun empirically investigating how well members of the general 
public process information about cases of gene-environment interaction (personal 
communication). We will have to wait for the results of her studies. In the meantime, there is 
reason to be skeptical about how well members of the general public will interpret cases of gene-
environment interaction; consider the fact that the scientific, ethical, and legal experts discussed 
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in chapters 2 and 3 have themselves misinterpreted the Caspi-Moffitt MAOA study as a ‘genetic 
predisposition to violence’. Should we expect members of the general public to do any better?   
 
4.3.2. Reconfiguring the Benefits and Burdens: Cases to Consider  
Consider the following hypothetical case: 
A husband and wife approach their pediatrician, seeking information about their infant 
regarding risk of allergic asthma. The mother suffers from severe allergic asthma, while 
the father does not. Upon further questioning, the physician learns that the mother did not 
attend daycare as a child, while the father did. The parents would like to know if there are 
any predictive tests available to gauge their child’s risk of developing allergic asthma, as 
well as whether there are preventive measures that they can take so as to combat the 
development of allergic asthma. The physician informs the parents that there is a known 
interactive predisposition for allergic asthma involving a functional polymorphism 
(NOS3_298) in coordination with exposure to daycare. He also informs them that there is 
a genetic test available for NOS3_298 status. The parents had not yet made any decision 
regarding daycare. They would like to test the child for his NOS3_298 status.    
 
This case is hypothetical in that there is not now a readily available test for the NOS3_298 
polymorphism studied by Hoffjan and her colleagues (2005). Nevertheless, it is worth 
considering the situation in which our pediatrician now finds herself, since it is likely that such a 
case would arise if a genetic test became available. Should she provide the test for the parents 
and acquire the infant’s genetic information, or is she justified in exercising a justified medical 
paternalism since the test is not being offered for the sake of any preventive medical 
intervention?  
 When we apply the analyses of Clayton (1997), Cohen (1998), and Ross (2002) to the 
interactive predisposition identified by Hoffjan and her colleagues (2005), I claim that there is 
good reason to allow parents to test their child for NOS3_298 status. The parents in our 
hypothetical case are particularly good candidates. The lack of exposure to daycare on the 
mother’s part combined with her allergic asthma suggests that she may carry the Asp/Asp 
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genotype. The father’s exposure to daycare and his lack of allergic asthma suggests that he may 
carry any of the other possible variants: Glu/Glu, Glu/Asp, or Asp/Asp. Thus, their child may 
carry either the Glu/Asp or the Asp/Asp variant of the NOS3_298 genotype. If the parents remain 
undecided about whether or not to expose their child to daycare, determining whether s/he 
carries the Glu/Asp or the Asp/Asp genotype could be a decisive factor in making that decision. 
With the Glu/Asp genotype, exposure to daycare slightly increases his risk of developing allergic 
asthma. With the Asp/Asp genotype, exposure to daycare drastically decreases his risk of 
developing allergic asthma. Of course, the potential intervention in this case is not a standard 
medical intervention; the test is not being undertaken for the purposes of potentially 
implementing a known, timely, medical intervention along the lines of a phenylalanine-free diet. 
But as Clayton (1997) and Ross (2002) point out, this need not be the only criterion of potential 
benefit for the child. Deciding whether or not to send their child to daycare will be a complicated 
parental decision involving the consideration of a number of financial, occupational, and 
philosophical factors that affect the family as a unit and the child as an individual. Obtaining the 
genetic information about the child could be a valuable contribution to this parental decision; if 
the child carries the Asp/Asp genotype, then there is a very good reason to lean towards daycare 
even in the face of financial or occupational costs. If the child carries the Glu/Asp genotype, then 
the threat is not so pressing, and the parents will have to decide whether the slight increase in 
risk associated with daycare attendance outweighs the costs of not attending.  
 The fact that the parents in this case also have control over manipulating the value of the 
environmental variable in this interactive predisposition also makes it a good candidate for going 
forward with the genetic test. The psychosocial burdens normally associated with a positive test 
result for a risky genotype need not apply to this case of an interactive predisposition. That is, 
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even if the child carries the Asp/Asp genotype, exposure to daycare ultimately makes the child 
relatively unlikely to develop allergic asthma. So there need not be stigmatization, 
discrimination, or a self-fulfilling prophecy in response to the genetic information. Of course, the 
pediatrician may be concerned that the parents will still fall trap to vulnerable child syndrome—
in this case, interpreting every bout of congestion or wheezy breath as the onset of asthma. The 
pediatrician can counteract this danger by ensuring that the parents do in fact understand the 
nature of this interactive predisposition for asthma, using it as a case to explicitly debunk the 
genetic essentialism that may motivate such an interpretation of the results.   
 Of course, if the parents have less control over manipulating the value of the 
environmental variable in this case, or if the parents have decided ahead of time to seek out or 
forgo daycare based on a particular parenting philosophy, then the cost-benefit analysis is 
altered. For instance, suppose our parents had decided ahead of time to forgo daycare because 
one of the parents does not work, and they cannot afford to send their child to daycare on the 
other parent’s salary. Should the physician still provide the genetic test to the parents even with 
the value of the environmental variable now essentially as fixed as the genetic variable? I think 
the analyses of Clayton (1997), Cohen (1998), and Ross (2002) still run their course here in favor 
of providing the genetic test; however, the calculus does not proceed in the same fashion. If the 
child bears the Glu/Asp genotype, then the parents can be comforted in the fact that lack of 
daycare actually decreases the child’s risk of developing allergic asthma. If the child bears the 
Asp/Asp genotype, then the parents can both prepare for the potential costs associated with a 
child with asthma and also take other measures which might take the place of daycare, such as 
exposure to social environments that include other young children.             
 73
 Consider another hypothetical case based upon the interactive predisposition associated 
with depression: 
A father approaches his 9-year-old daughter’s pediatrician, asking to have her genotyped 
to determine which variant of the serotonin transporter gene she carries. His wife, his 
daughter’s mother, was recently killed in an automobile accident, and the father is 
concerned that this stressful life event, in coordination with certain allelic variants of the 
serotonin transporter gene, may make his daughter at high risk of developing depression 
in subsequent years. He would like to genotype his daughter so as to determine whether 
she is at increased risk of developing depression in light of this environmental stressor. 
 
This case is also hypothetical in that there is not now a readily available test for the serotonin 
transporter gene. Still, as mentioned in the introduction to this chapter, Neuromark is seeking 
FDA approval for such a test with the expressed idea being that parents may want to utilize such 
information by genotyping their children. Should our pediatrician provide the genetic test for the 
daughter? For this particular case, I do not believe that even the revisionist analyses of Clayton 
(1997), Cohen (1998), and Ross (2002) support providing the test. To begin, the child has thus 
far experienced only one stressful life event. If we recall the reaction norm graph found in Figure 
3.3a above, we see that all three variants of the serotonin transporter gene (s/s, s/l, and l/l) are 
virtually identical in their risk-status at exposure to one stressful life event. The probability of 
depression given one stressful life event for individuals from the Caspi-Moffitt study was 0.11 
regardless of which genetic variant s/he carried. Obtaining the child’s genetic information, then, 
in no way suggests a relatively elevated or decreased risk of developing depression at this point. 
Of course, we are all at risk of experiencing stressful life events, and if this young girl 
subsequently experiences one or more stressful life events on top of this first stressor, then 
carrying the s/s genotype would put her at a relatively increased risk of developing depression 
compared to either the s/l or the l/l genotypes. At four or more stressful life events, for instance, 
individuals from the Caspi-Moffitt study bearing the s/s genotype had a probability of 0.43 of 
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developing depression; individuals bearing the s/l genotype had a probability of 0.28 of 
developing depression; and individuals bearing the l/l genotype had a probability of 0.21 of 
developing depression. Might not the father argue that life is stressful, and thus he should obtain 
his daughter’s genetic information, so that if these subsequent stressful life events do unfold, 
then he will know that she is at increased risk of developing depression? On the one hand, we 
should be sympathetic to this father’s concern for his daughter and appreciate his interest in 
anticipating future stressors in light of the one he and his daughter have already experienced. 
Yet, what preventive or responsive action can the father, daughter, or health care provider take 
for the daughter if she carries the s/s genotype that they would not already take if she carries the 
l/l genotype in the face of subsequent stressful life events? Suppose, for instance, the father 
subsequently loses his job and is forced to sell their home and move with his daughter to a 
smaller apartment in another state, or suppose the daughter loses a close friend to a tragic 
accident. Should the father treat his daughter any differently in response to these stressful life 
events if she carries the s/s genotype than if she carries the l/l genotype? Not at all. In both cases, 
he should respond with appropriate familial, social, and perhaps psychiatric support systems that 
help her cope with the mounting stressful life events that she is experiencing. The increasing 
number of stressful life events puts her at increased risk of developing depression regardless of 
her genotypic status. So there is no sense in which obtaining the genetic information provides a 
potential benefit in the form of suggesting a course of preventive intervention that would not 
already be employed for any of the other genetic variants. 
 Moreover, there is also a clear and significant risk associated with a genetic test revealing 
that the child bears the s/s genotype. Bearing the s/s genotype, in coordination with exposure to 
multiple stressful life events, does point to a relatively increased risk of developing depression. 
 75
Though the outcome of depression is by no means a certainty, there is the very real danger that 
the daughter, her father, and those in their social network will begin treating depression as an 
inevitability. She may be seen as getting hit with that double-dose of bad luck: the high-risk 
genotype in the high-risk environment. Almost all adolescents experience brief periods of 
depression; with the double-dose, though, even these normal bouts of depression may be 
interpreted as the onset of clinical depression. Thus, the standard burdens associated with testing 
a child for a genetic predisposition, such as fears of stigmatization, discrimination, or a self-
fulfilling prophecy, are likely to be magnified in this case of an interactive predisposition. When 
we consider the fact that the value of the environmental variable is out of anyone’s control, that 
responding to the environmental variable would not be changed with information about the 
genetic variable, and that information about the genetic variable lends itself to clear and 
significant risks, I argue that the genetic test should not be offered in this case even if requested 
by the parent.        
 Consider one more hypothetical case, this time for the interactive predisposition 
associated with schizophrenia: 
A couple has approached an adoption agency seeking a child for adoption. Before 
accepting a child for adoption, however, they would like to know whether or not the child 
is at high-risk of developing schizophrenia. They are not prepared to deal with a child 
with a severe psychiatric disease, and so they would like to rule out that risk. Thus, they 
explain to the agency that they will eagerly adopt a child at low-risk of developing 
schizophrenia but will be unwilling to adopt a child at high-risk of developing 
schizophrenia. 
 
Should the adoption agency provide the prospective adoptive couple with information about the 
risk status of an adoptee? In this case, the interactive predisposition associated with 
schizophrenia identified by Wahlberg and his associates is particularly relevant (Wahlberg et al. 
1997). The danger with incorporating genetic information about an adoptee into the adoption 
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decision, remember, is that it risks making the child a “commodity undergoing quality control” 
(Wertz, Fanos, and Reilly 1994), and that it may adversely affect the child’s chances of adoption 
(ASHG/ACMG 2000). With an interactive predisposition, though, the genotype alone does not 
confer risk status; that is, the adoptee cannot yet be labeled ‘high risk’ or ‘low risk’ until the 
environmental conditions of development have been experienced. In the Wahlberg et al. (1997) 
study, those conditions of development concerned the communication patterns in the adoptive 
parents. The adoption agency, then, could comply with the prospective adoptive parents request 
and obtain information about the adoptee’s familial history of schizophrenia. However, in turn, 
the adoption agency would also need to request that the prospective adoptive parents undergo 
testing for evidence of communication deviance. Because we are dealing with a case of 
interactive predisposition, the risk status of the adoptee can only be predicted once information 
about both the genetic and the environmental information are obtained. If the prospective 
adoptive parents show evidence of communication deviance, then the adoption agency can seek 
out a potential adoptee without a familial history of schizophrenia.  
 Ultimately, then, I claim that the adoption agency should obtain the genetic information 
about the adoptee as it applies to this interactive predisposition for schizophrenia. In this case, 
there is no at-risk genotype; there is only an at-risk gene-environment combination. Thus, the 
familial history for the adoptee does not by itself predict his or her risk status, and so the 
standard burden associated with genetically testing adoptees is eliminated. The risk status comes 
from joining that family history with information about the communication patters in the 
prospective adoptive parents. The challenge, then, is pairing adoptees with prospective adoptive 
parents so as to minimize the risk of schizophrenia.         
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4.4. Conclusion  
This chapter has been devoted to considering how cases of interactive predisposition should be 
taken into account in the ongoing debates over genetic testing in children. Thus far, the ethical 
debates have focused solely on cases of genetic determinism and genetic predisposition. As cases 
of known interactive predisposition become commonplace, however, the ethical considerations 
must be expanded so as to anticipate tests for genes implicated in these cases. Cases of 
interactive predisposition reconfigure the cost-benefit analysis involved in deciding whether or 
not to genetically test a child. In general, the need to incorporate information about the 
environmental variable into the evaluation of risk status raises important questions about the 
extent to which the value of that variable can be manipulated and the extent to which information 
about the value of that variable can actually be obtained. Moreover, the need to incorporate 
information about the environmental variable into the evaluation of risk status requires updated 
empirical studies about the extent to which parents will understand the probabilistic information 
involved in cases of interactive predisposition. The real challenge involves applying these 
general considerations to particular cases of interactive predisposition. I have considered several 
hypothetical cases and argued that the reconfigured cost-benefit analysis warrants genetic testing 
children in some cases, and does not warrant genetic testing children in other cases.  
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5. CONCLUSION 
A conclusion can serve different purposes. One common function involves looking backwards 
and restating the arguments/conclusions of the earlier chapters so as to bring them all together in 
one place. Another function involves looking forwards and considering issues that could not be 
discussed directly in the earlier chapters but which are related in some way and deserve attention, 
perhaps pointing to directions for future research. Throughout the thesis, I have tried to tie the 
arguments/conclusions of the earlier chapters into the subsequent chapters. Thus, the backwards-
looking function would be redundant here. Instead, I will consider some of the issues related to 
interactive predispositions which did not fit neatly into the earlier chapters. I will frame these 
considerations around two possible criticisms that might be leveled against my discussion of 
interactive predispositions, one criticism suggesting that I have overcomplicated the problem, 
one criticism suggesting that I have oversimplified the problem.  
First, a critic might argue that I have overcomplicated the analysis of interactive 
predispositions by placing so much emphasis on the change in rank and demanding that a new 
concept be introduced to capture these cases as distinct from cases of a change in scale. A more 
nuanced concept of genetic predisposition, the critic argues, will work just fine. Consider the 
Caspi-Moffitt study on depression. The critic admits that the norms of reaction change rank. But 
the critic then argues that we can still say that, in general, individuals with the s/s genotype are 
the genetically predisposed population relative to individuals with either the s/l or the l/l 
genotypes. That is, if we average the probabilities of depression across all of the environments, 
then individuals with the s/s genotype are at a relatively increased risk of developing depression 
in comparison to individuals with either the s/l or the l/l genotypes. Why not, the critic asks, just 
forget about the change in rank and the concept of an interactive predisposition and instead focus 
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on the average risk across the environments and then return to the concept of a genetic 
predisposition, albeit an averaged genetic predisposition? 
 This criticism is essentially a variant on the utilitarian comparison of subgroups 
introduced in the context of screening newborns for MAOA status (see section 3.3 above). And, 
as such, it faces the same problem that the utilitarian comparison of subgroups faced. The 
utilitarian comparison of subgroups, remember, pushed through the interventionist’s dilemma by 
comparing subgroups in the Caspi-Moffitt MAOA study and noting that, in two of the three 
environments, the low-MAOA activity population was at the relatively increased risk of 
developing ASPD, thus concluding that an MAOA boost for all individuals with low-MAOA 
activity would be in order. The problem with this analysis, however, was the fact that only 1/3 of 
the population in the Caspi-Moffitt study actually fell into these two environments; most of the 
study population did not experience childhood maltreatment, and so an MAOA boost would 
actually increase the risk of developing ASPD for most of the population. The same can be said 
for the depression study. Even though individuals with the s/s genotype are at a relatively 
increased risk of depression in environments with multiple stressful life events, we should not 
then assume that individuals with the s/s genotype are the ones who most often develop 
depression in the general population. If most of the population falls into environments with zero 
or one stressful life event, then individuals with the s/s genotype are, in general, not more at risk 
than the individuals with the other genotypes. So the concept of an average genetic 
predisposition fails to capture the relative frequency with which individuals actually find 
themselves in the different environments.  
 Now, the critic could here opt for an even more nuanced interpretation of genetic 
predisposition so as to continue applying this concept to cases of G×E resulting in a change of 
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rank. We shouldn’t focus on average risk across the environments, treating each subgroup as 
equal; we should focus on weighted average risk across the environments, weighting each 
subgroup based upon how many individuals in the population actually fall into that subgroup. 
The result, the critic now points out, would be a weighted average genetic predisposition. This is 
certainly a legitimate response to the problem. But why go to such extremes to salvage the 
concept of a genetic predisposition? The whole point of chapters 3 and 4 was to draw attention to 
the unique ethical questions that arise when the norms of reaction change rank. Reverting to a 
weighted average genetic predisposition completely ignores this cross-over effect and 
generalizes across all of the environments, thereby missing the ethical questions that were raised 
in those chapters. As Parens points out, “conceptual tools—basic concepts and distinctions” are 
needed in the scientific, public, and ethical discourses about behavioral genetics (Parens 2004, 
S30). In light of the important difference between cases of G×E resulting in a change of scale 
and cases of G×E resulting in a change of rank, differentiating between genetic predispositions 
and interactive predispositions draws attention to this difference, whereas a weighted average 
genetic predisposition, nuanced or not, only ignores the difference.  
Another critic of my analysis might suggest that, rather than overcomplicating the 
problem, I have actually oversimplified it. The criticism here would be that my analyses of the 
diseases and disorders resulting from interactive predispositions only contain information about 
the particular genetic and environmental variables involved in the studies that I discuss; in fact, 
the diseases and disorders are probably also affected by many other genetic and environmental 
variables that do not play out in the same manner. Consider the interactive predisposition for 
thought disorder, the trait symptomatic of schizophrenia. Wahlberg and his colleagues (1997) 
found an interactive predisposition for genetic risk, exposure to communication deviance, and 
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the subsequent development of thought disorder. Children of biological mothers who were 
schizophrenic were more likely to develop thought disorder than children of biological mothers 
who were not schizophrenic when these two groups were exposed to communication deviance 
from adoptive parents. Children of biological mothers who were schizophrenic were less likely to 
develop thought disorder than children of biological mothers who were not schizophrenic when 
these two groups were not exposed to communication deviance from adoptive parents. Still, an 
adoptee’s adoptive environment consists of many factors, communication patterns in the 
adoptive parents only being one of them. There are also environmental factors involving 
nutrition, education, and socioeconomic status, to name just a few. The critic admits that there 
may be an interactive predisposition for thought disorder involving genetic risk and this 
particular environmental variable. But, the critic continues, in general the children of biological 
mothers who were schizophrenic are consistently at increased risk of developing thought 
disorder relative to the children of biological mothers who were not schizophrenic across most of 
the other environmental variables. That is, there may be an interactive predisposition with this 
one environmental variable, but the norm is a genetic predisposition with most other 
environmental variables.  
 I take this to be a valid point, but I do not see it as fundamentally undermining my 
analysis of interactive predispositions. The conclusion to draw from this criticism is simply the 
fact that all of the empirical information regarding the genetic and environmental variables 
implicated in the development of schizophrenia (or any trait for that matter) should be 
incorporated into the analysis, be it an analysis concerning the genetic screening of embryos, 
fetuses, newborns, or children. If there are interactive predispositions involving some genetic and 
environmental variables and genetic predispositions involving others, then the analysis must 
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proceed by taking into consideration both the traditional questions raised about genetic 
predispositions as well as the new questions I have raised concerning interactive predispositions. 
Consider the adoption agency deciding whether or not to inform the prospective adoptive couple 
about the risk status of potential adoptees with regards to schizophrenia. If there is an interactive 
predisposition involving communication deviance but a genetic predisposition involving most of 
the other environmental variables present in the adoptive home, then the adoptive agency would 
be wise to essentially treat the case as a genetic predisposition and consider all of the potential 
burdens associated with testing adoptees for genetic predispositions to psychiatric disorders 
alongside the issues raised by the interactive predisposition. The point is that empirical 
information about an interactive predisposition for a particular trait only provides information 
regarding the particular genetic and environmental variables involved in the study. This can be 
valuable when deciding how (or whether or not) to manipulate that particular environmental 
variable or the product of that particular genetic variable, but it should not be taken to imply that 
there is an interactive predisposition for that particular trait for all genetic and environmental 
variables. 
 Ultimately, I have argued in this thesis that the difference between cases of G×E that 
result in a change of scale and cases of G×E that result in a change of rank warrants distinct 
concepts. This argument was based both on the conceptual incoherence that follows from 
characterizing cases of G×E that result in a change of rank with the concept of a genetic 
predisposition, and also the unique ethical questions surrounding embryonic, fetal, newborn, and 
childhood genetic screening that arise for these cases of G×E that result in a change of rank. 
Even a nuanced concept of genetic predisposition, such as weighted average genetic 
predisposition, will miss these unique questions. However, that being said, the analysis of any 
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particular case will most likely involve a mix of the traditional questions relating to genetic 
predispositions and the questions that I have raised relating to interactive predispositions.     
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